JPH0332360B2 - - Google Patents
Info
- Publication number
- JPH0332360B2 JPH0332360B2 JP59155638A JP15563884A JPH0332360B2 JP H0332360 B2 JPH0332360 B2 JP H0332360B2 JP 59155638 A JP59155638 A JP 59155638A JP 15563884 A JP15563884 A JP 15563884A JP H0332360 B2 JPH0332360 B2 JP H0332360B2
- Authority
- JP
- Japan
- Prior art keywords
- composition
- urea
- cation
- pyruvate
- composition according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 239000000203 mixture Substances 0.000 claims abstract description 40
- 150000001768 cations Chemical class 0.000 claims abstract description 12
- 108020005115 Pyruvate Kinase Proteins 0.000 claims abstract description 8
- 102000013009 Pyruvate Kinase Human genes 0.000 claims abstract description 8
- 230000002255 enzymatic effect Effects 0.000 claims abstract description 8
- 229930029653 phosphoenolpyruvate Natural products 0.000 claims abstract description 8
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims abstract description 7
- 108010042687 Pyruvate Oxidase Proteins 0.000 claims abstract description 7
- 229910052816 inorganic phosphate Inorganic materials 0.000 claims abstract description 6
- 229910052708 sodium Inorganic materials 0.000 claims abstract description 6
- BVKZGUZCCUSVTD-UHFFFAOYSA-M Bicarbonate Chemical compound OC([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-M 0.000 claims abstract description 5
- 239000000872 buffer Substances 0.000 claims abstract description 5
- 239000000276 potassium ferrocyanide Substances 0.000 claims abstract description 5
- 239000000264 sodium ferrocyanide Substances 0.000 claims abstract description 5
- 235000012247 sodium ferrocyanide Nutrition 0.000 claims abstract description 5
- XOGGUFAVLNCTRS-UHFFFAOYSA-N tetrapotassium;iron(2+);hexacyanide Chemical compound [K+].[K+].[K+].[K+].[Fe+2].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-] XOGGUFAVLNCTRS-UHFFFAOYSA-N 0.000 claims abstract description 4
- DTBNBXWJWCWCIK-UHFFFAOYSA-N phosphoenolpyruvic acid Chemical compound OC(=O)C(=C)OP(O)(O)=O DTBNBXWJWCWCIK-UHFFFAOYSA-N 0.000 claims abstract 2
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 claims description 90
- 239000004202 carbamide Substances 0.000 claims description 52
- RLFWWDJHLFCNIJ-UHFFFAOYSA-N 4-aminoantipyrine Chemical compound CN1C(C)=C(N)C(=O)N1C1=CC=CC=C1 RLFWWDJHLFCNIJ-UHFFFAOYSA-N 0.000 claims description 12
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 claims description 12
- 108090000856 Lyases Proteins 0.000 claims description 11
- 102000004317 Lyases Human genes 0.000 claims description 11
- 102000003992 Peroxidases Human genes 0.000 claims description 10
- 108040007629 peroxidase activity proteins Proteins 0.000 claims description 9
- CCVYRRGZDBSHFU-UHFFFAOYSA-N (2-hydroxyphenyl)acetic acid Chemical compound OC(=O)CC1=CC=CC=C1O CCVYRRGZDBSHFU-UHFFFAOYSA-N 0.000 claims description 8
- ZKHQWZAMYRWXGA-UHFFFAOYSA-N Adenosine triphosphate Natural products C1=NC=2C(N)=NC=NC=2N1C1OC(COP(O)(=O)OP(O)(=O)OP(O)(O)=O)C(O)C1O ZKHQWZAMYRWXGA-UHFFFAOYSA-N 0.000 claims description 8
- 229960002363 thiamine pyrophosphate Drugs 0.000 claims description 5
- 235000008170 thiamine pyrophosphate Nutrition 0.000 claims description 5
- 239000011678 thiamine pyrophosphate Substances 0.000 claims description 5
- YXVCLPJQTZXJLH-UHFFFAOYSA-N thiamine(1+) diphosphate chloride Chemical compound [Cl-].CC1=C(CCOP(O)(=O)OP(O)(O)=O)SC=[N+]1CC1=CN=C(C)N=C1N YXVCLPJQTZXJLH-UHFFFAOYSA-N 0.000 claims description 5
- 239000007788 liquid Substances 0.000 claims description 4
- 150000002978 peroxides Chemical class 0.000 claims description 4
- KJCVRFUGPWSIIH-UHFFFAOYSA-N 1-naphthol Chemical compound C1=CC=C2C(O)=CC=CC2=C1 KJCVRFUGPWSIIH-UHFFFAOYSA-N 0.000 claims description 3
- 150000004982 aromatic amines Chemical class 0.000 claims description 3
- 238000005259 measurement Methods 0.000 claims description 3
- 230000002441 reversible effect Effects 0.000 claims description 3
- 230000008878 coupling Effects 0.000 claims description 2
- 238000010168 coupling process Methods 0.000 claims description 2
- 238000005859 coupling reaction Methods 0.000 claims description 2
- 230000001590 oxidative effect Effects 0.000 claims description 2
- 239000012042 active reagent Substances 0.000 claims 2
- 238000004040 coloring Methods 0.000 claims 2
- ZKHQWZAMYRWXGA-KQYNXXCUSA-J ATP(4-) Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](COP([O-])(=O)OP([O-])(=O)OP([O-])([O-])=O)[C@@H](O)[C@H]1O ZKHQWZAMYRWXGA-KQYNXXCUSA-J 0.000 claims 1
- JLVVSXFLKOJNIY-UHFFFAOYSA-N Magnesium ion Chemical compound [Mg+2] JLVVSXFLKOJNIY-UHFFFAOYSA-N 0.000 claims 1
- NPYPAHLBTDXSSS-UHFFFAOYSA-N Potassium ion Chemical compound [K+] NPYPAHLBTDXSSS-UHFFFAOYSA-N 0.000 claims 1
- 229940096405 magnesium cation Drugs 0.000 claims 1
- 238000005691 oxidative coupling reaction Methods 0.000 claims 1
- 238000000034 method Methods 0.000 abstract description 29
- ZKHQWZAMYRWXGA-KQYNXXCUSA-N Adenosine triphosphate Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]1O ZKHQWZAMYRWXGA-KQYNXXCUSA-N 0.000 abstract description 12
- 210000001124 body fluid Anatomy 0.000 abstract description 5
- 239000010839 body fluid Substances 0.000 abstract description 5
- 229910019142 PO4 Inorganic materials 0.000 abstract description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 abstract description 2
- 239000010452 phosphate Substances 0.000 abstract description 2
- 108010010296 urea carboxylase (hydrolyzing) Proteins 0.000 abstract 2
- 238000008083 Urea Assay Methods 0.000 abstract 1
- 238000003556 assay Methods 0.000 abstract 1
- XPPKVPWEQAFLFU-UHFFFAOYSA-J diphosphate(4-) Chemical compound [O-]P([O-])(=O)OP([O-])([O-])=O XPPKVPWEQAFLFU-UHFFFAOYSA-J 0.000 abstract 1
- 235000011180 diphosphates Nutrition 0.000 abstract 1
- 239000012085 test solution Substances 0.000 abstract 1
- 238000006243 chemical reaction Methods 0.000 description 19
- 239000003153 chemical reaction reagent Substances 0.000 description 14
- 239000011159 matrix material Substances 0.000 description 14
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 12
- 102000004190 Enzymes Human genes 0.000 description 10
- 108090000790 Enzymes Proteins 0.000 description 10
- 238000004458 analytical method Methods 0.000 description 10
- XTWYTFMLZFPYCI-KQYNXXCUSA-N 5'-adenylphosphoric acid Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](COP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]1O XTWYTFMLZFPYCI-KQYNXXCUSA-N 0.000 description 9
- 238000002835 absorbance Methods 0.000 description 9
- 239000000243 solution Substances 0.000 description 9
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 8
- -1 ammonium ions Chemical class 0.000 description 8
- 150000002989 phenols Chemical class 0.000 description 8
- 238000012360 testing method Methods 0.000 description 8
- XTWYTFMLZFPYCI-UHFFFAOYSA-N Adenosine diphosphate Natural products C1=NC=2C(N)=NC=NC=2N1C1OC(COP(O)(=O)OP(O)(O)=O)C(O)C1O XTWYTFMLZFPYCI-UHFFFAOYSA-N 0.000 description 7
- 108010046334 Urease Proteins 0.000 description 7
- 229960001456 adenosine triphosphate Drugs 0.000 description 7
- DTBNBXWJWCWCIK-UHFFFAOYSA-K phosphonatoenolpyruvate Chemical compound [O-]C(=O)C(=C)OP([O-])([O-])=O DTBNBXWJWCWCIK-UHFFFAOYSA-K 0.000 description 7
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 6
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- LCTONWCANYUPML-UHFFFAOYSA-M Pyruvate Chemical compound CC(=O)C([O-])=O LCTONWCANYUPML-UHFFFAOYSA-M 0.000 description 6
- 210000004369 blood Anatomy 0.000 description 6
- 239000008280 blood Substances 0.000 description 6
- 239000000126 substance Substances 0.000 description 6
- 210000002700 urine Anatomy 0.000 description 6
- 239000000975 dye Substances 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- 229910021529 ammonia Inorganic materials 0.000 description 4
- 230000008901 benefit Effects 0.000 description 4
- 238000001514 detection method Methods 0.000 description 4
- 238000006911 enzymatic reaction Methods 0.000 description 4
- WQYVRQLZKVEZGA-UHFFFAOYSA-N hypochlorite Chemical compound Cl[O-] WQYVRQLZKVEZGA-UHFFFAOYSA-N 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- 150000004780 naphthols Chemical class 0.000 description 4
- 230000004044 response Effects 0.000 description 4
- JKMHFZQWWAIEOD-UHFFFAOYSA-N 2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid Chemical compound OCC[NH+]1CCN(CCS([O-])(=O)=O)CC1 JKMHFZQWWAIEOD-UHFFFAOYSA-N 0.000 description 3
- 239000004744 fabric Substances 0.000 description 3
- 239000012530 fluid Substances 0.000 description 3
- 229930027945 nicotinamide-adenine dinucleotide Natural products 0.000 description 3
- BOPGDPNILDQYTO-NNYOXOHSSA-N nicotinamide-adenine dinucleotide Chemical compound C1=CCC(C(=O)N)=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OC[C@@H]2[C@H]([C@@H](O)[C@@H](O2)N2C3=NC=NC(N)=C3N=C2)O)O1 BOPGDPNILDQYTO-NNYOXOHSSA-N 0.000 description 3
- 230000003647 oxidation Effects 0.000 description 3
- 238000007254 oxidation reaction Methods 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- JWAZRIHNYRIHIV-UHFFFAOYSA-N 2-naphthol Chemical compound C1=CC=CC2=CC(O)=CC=C21 JWAZRIHNYRIHIV-UHFFFAOYSA-N 0.000 description 2
- JRBJSXQPQWSCCF-UHFFFAOYSA-N 3,3'-Dimethoxybenzidine Chemical compound C1=C(N)C(OC)=CC(C=2C=C(OC)C(N)=CC=2)=C1 JRBJSXQPQWSCCF-UHFFFAOYSA-N 0.000 description 2
- DVLFYONBTKHTER-UHFFFAOYSA-N 3-(N-morpholino)propanesulfonic acid Chemical compound OS(=O)(=O)CCCN1CCOCC1 DVLFYONBTKHTER-UHFFFAOYSA-N 0.000 description 2
- YRNWIFYIFSBPAU-UHFFFAOYSA-N 4-[4-(dimethylamino)phenyl]-n,n-dimethylaniline Chemical compound C1=CC(N(C)C)=CC=C1C1=CC=C(N(C)C)C=C1 YRNWIFYIFSBPAU-UHFFFAOYSA-N 0.000 description 2
- FEPBITJSIHRMRT-UHFFFAOYSA-N 4-hydroxybenzenesulfonic acid Chemical compound OC1=CC=C(S(O)(=O)=O)C=C1 FEPBITJSIHRMRT-UHFFFAOYSA-N 0.000 description 2
- 240000003291 Armoracia rusticana Species 0.000 description 2
- 235000011330 Armoracia rusticana Nutrition 0.000 description 2
- 101000950981 Bacillus subtilis (strain 168) Catabolic NAD-specific glutamate dehydrogenase RocG Proteins 0.000 description 2
- BPYKTIZUTYGOLE-IFADSCNNSA-N Bilirubin Chemical compound N1C(=O)C(C)=C(C=C)\C1=C\C1=C(C)C(CCC(O)=O)=C(CC2=C(C(C)=C(\C=C/3C(=C(C=C)C(=O)N\3)C)N2)CCC(O)=O)N1 BPYKTIZUTYGOLE-IFADSCNNSA-N 0.000 description 2
- 102000016901 Glutamate dehydrogenase Human genes 0.000 description 2
- 239000007995 HEPES buffer Substances 0.000 description 2
- JOCBASBOOFNAJA-UHFFFAOYSA-N N-tris(hydroxymethyl)methyl-2-aminoethanesulfonic acid Chemical compound OCC(CO)(CO)NCCS(O)(=O)=O JOCBASBOOFNAJA-UHFFFAOYSA-N 0.000 description 2
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 229910052783 alkali metal Inorganic materials 0.000 description 2
- POJWUDADGALRAB-UHFFFAOYSA-N allantoin Chemical compound NC(=O)NC1NC(=O)NC1=O POJWUDADGALRAB-UHFFFAOYSA-N 0.000 description 2
- 150000001412 amines Chemical class 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 238000009833 condensation Methods 0.000 description 2
- 230000005494 condensation Effects 0.000 description 2
- GGSUCNLOZRCGPQ-UHFFFAOYSA-N diethylaniline Chemical compound CCN(CC)C1=CC=CC=C1 GGSUCNLOZRCGPQ-UHFFFAOYSA-N 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 239000003365 glass fiber Substances 0.000 description 2
- BTIJJDXEELBZFS-QDUVMHSLSA-K hemin Chemical compound CC1=C(CCC(O)=O)C(C=C2C(CCC(O)=O)=C(C)\C(N2[Fe](Cl)N23)=C\4)=N\C1=C/C2=C(C)C(C=C)=C3\C=C/1C(C)=C(C=C)C/4=N\1 BTIJJDXEELBZFS-QDUVMHSLSA-K 0.000 description 2
- 210000003734 kidney Anatomy 0.000 description 2
- OKVJCVWFVRATSG-UHFFFAOYSA-N m-hydroxybenzyl alcohol Natural products OCC1=CC=CC(O)=C1 OKVJCVWFVRATSG-UHFFFAOYSA-N 0.000 description 2
- IWYDHOAUDWTVEP-UHFFFAOYSA-N mandelic acid Chemical compound OC(=O)C(O)C1=CC=CC=C1 IWYDHOAUDWTVEP-UHFFFAOYSA-N 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 238000012544 monitoring process Methods 0.000 description 2
- CQRYARSYNCAZFO-UHFFFAOYSA-N o-hydroxybenzyl alcohol Natural products OCC1=CC=CC=C1O CQRYARSYNCAZFO-UHFFFAOYSA-N 0.000 description 2
- 235000019645 odor Nutrition 0.000 description 2
- 238000005580 one pot reaction Methods 0.000 description 2
- BVJSUAQZOZWCKN-UHFFFAOYSA-N p-hydroxybenzyl alcohol Chemical compound OCC1=CC=C(O)C=C1 BVJSUAQZOZWCKN-UHFFFAOYSA-N 0.000 description 2
- 239000000049 pigment Substances 0.000 description 2
- 210000002381 plasma Anatomy 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 210000002966 serum Anatomy 0.000 description 2
- 239000003826 tablet Substances 0.000 description 2
- 239000010936 titanium Substances 0.000 description 2
- 229910052719 titanium Inorganic materials 0.000 description 2
- 239000012224 working solution Substances 0.000 description 2
- SNTWKPAKVQFCCF-UHFFFAOYSA-N 2,3-dihydro-1h-triazole Chemical compound N1NC=CN1 SNTWKPAKVQFCCF-UHFFFAOYSA-N 0.000 description 1
- DEENCNYPFDWDSA-UHFFFAOYSA-N 2-ethyl-1,3-benzothiazole-6-sulfonic acid Chemical compound C1=C(S(O)(=O)=O)C=C2SC(CC)=NC2=C1 DEENCNYPFDWDSA-UHFFFAOYSA-N 0.000 description 1
- KQMCGGGTJKNIMC-UHFFFAOYSA-N 2-hydroxy-3-propyl-2h-furan-5-one Chemical compound CCCC1=CC(=O)OC1O KQMCGGGTJKNIMC-UHFFFAOYSA-N 0.000 description 1
- IULJSGIJJZZUMF-UHFFFAOYSA-N 2-hydroxybenzenesulfonic acid Chemical compound OC1=CC=CC=C1S(O)(=O)=O IULJSGIJJZZUMF-UHFFFAOYSA-N 0.000 description 1
- NEGFNJRAUMCZMY-UHFFFAOYSA-N 3-(dimethylamino)benzoic acid Chemical compound CN(C)C1=CC=CC(C(O)=O)=C1 NEGFNJRAUMCZMY-UHFFFAOYSA-N 0.000 description 1
- ALKYHXVLJMQRLQ-UHFFFAOYSA-N 3-Hydroxy-2-naphthoate Chemical class C1=CC=C2C=C(O)C(C(=O)O)=CC2=C1 ALKYHXVLJMQRLQ-UHFFFAOYSA-N 0.000 description 1
- BMUDPLZKKRQECS-UHFFFAOYSA-K 3-[18-(2-carboxyethyl)-8,13-bis(ethenyl)-3,7,12,17-tetramethylporphyrin-21,24-diid-2-yl]propanoic acid iron(3+) hydroxide Chemical compound [OH-].[Fe+3].[N-]1C2=C(C)C(CCC(O)=O)=C1C=C([N-]1)C(CCC(O)=O)=C(C)C1=CC(C(C)=C1C=C)=NC1=CC(C(C)=C1C=C)=NC1=C2 BMUDPLZKKRQECS-UHFFFAOYSA-K 0.000 description 1
- ZCLXQTGLKVQKFD-UHFFFAOYSA-N 3-hydroxybenzenesulfonic acid Chemical compound OC1=CC=CC(S(O)(=O)=O)=C1 ZCLXQTGLKVQKFD-UHFFFAOYSA-N 0.000 description 1
- ASFYHTGWWLFSDZ-UHFFFAOYSA-N 5-chloro-2-hydroxybenzenesulfonic acid Chemical compound OC1=CC=C(Cl)C=C1S(O)(=O)=O ASFYHTGWWLFSDZ-UHFFFAOYSA-N 0.000 description 1
- POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 description 1
- 208000037157 Azotemia Diseases 0.000 description 1
- 241000222122 Candida albicans Species 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 1
- 102000016938 Catalase Human genes 0.000 description 1
- 108010053835 Catalase Proteins 0.000 description 1
- 241000235646 Cyberlindnera jadinii Species 0.000 description 1
- 101710088194 Dehydrogenase Proteins 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- OWXMKDGYPWMGEB-UHFFFAOYSA-N HEPPS Chemical compound OCCN1CCN(CCCS(O)(=O)=O)CC1 OWXMKDGYPWMGEB-UHFFFAOYSA-N 0.000 description 1
- 102000001554 Hemoglobins Human genes 0.000 description 1
- 108010054147 Hemoglobins Proteins 0.000 description 1
- 108090000604 Hydrolases Proteins 0.000 description 1
- RHGKLRLOHDJJDR-BYPYZUCNSA-N L-citrulline Chemical compound NC(=O)NCCC[C@H]([NH3+])C([O-])=O RHGKLRLOHDJJDR-BYPYZUCNSA-N 0.000 description 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
- 102000003855 L-lactate dehydrogenase Human genes 0.000 description 1
- 108700023483 L-lactate dehydrogenases Proteins 0.000 description 1
- 239000007993 MOPS buffer Substances 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- BAVYZALUXZFZLV-UHFFFAOYSA-N Methylamine Chemical compound NC BAVYZALUXZFZLV-UHFFFAOYSA-N 0.000 description 1
- JLTDJTHDQAWBAV-UHFFFAOYSA-N N,N-dimethylaniline Chemical group CN(C)C1=CC=CC=C1 JLTDJTHDQAWBAV-UHFFFAOYSA-N 0.000 description 1
- RHGKLRLOHDJJDR-UHFFFAOYSA-N Ndelta-carbamoyl-DL-ornithine Natural products OC(=O)C(N)CCCNC(N)=O RHGKLRLOHDJJDR-UHFFFAOYSA-N 0.000 description 1
- 108700020962 Peroxidase Proteins 0.000 description 1
- 206010034972 Photosensitivity reaction Diseases 0.000 description 1
- 239000004952 Polyamide Substances 0.000 description 1
- 239000004793 Polystyrene Substances 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 101710204616 Pyruvate kinase 2 Proteins 0.000 description 1
- 244000061456 Solanum tuberosum Species 0.000 description 1
- 235000002595 Solanum tuberosum Nutrition 0.000 description 1
- JZRWCGZRTZMZEH-UHFFFAOYSA-N Thiamine Natural products CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N JZRWCGZRTZMZEH-UHFFFAOYSA-N 0.000 description 1
- 239000007983 Tris buffer Substances 0.000 description 1
- PNNCWTXUWKENPE-UHFFFAOYSA-N [N].NC(N)=O Chemical compound [N].NC(N)=O PNNCWTXUWKENPE-UHFFFAOYSA-N 0.000 description 1
- LIPOUNRJVLNBCD-UHFFFAOYSA-N acetyl dihydrogen phosphate Chemical compound CC(=O)OP(O)(O)=O LIPOUNRJVLNBCD-UHFFFAOYSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 239000002390 adhesive tape Substances 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 150000001340 alkali metals Chemical class 0.000 description 1
- 229910052784 alkaline earth metal Inorganic materials 0.000 description 1
- 239000012670 alkaline solution Substances 0.000 description 1
- 229960000458 allantoin Drugs 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- 239000002585 base Substances 0.000 description 1
- 229950011260 betanaphthol Drugs 0.000 description 1
- 239000013060 biological fluid Substances 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000000279 calcium ferrocyanide Substances 0.000 description 1
- 235000012251 calcium ferrocyanide Nutrition 0.000 description 1
- 238000011088 calibration curve Methods 0.000 description 1
- 229940095731 candida albicans Drugs 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-N carbonic acid Chemical class OC(O)=O BVKZGUZCCUSVTD-UHFFFAOYSA-N 0.000 description 1
- 239000000919 ceramic Substances 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- YARKTHNUMGKMGS-LQGKIZFRSA-N chembl3193980 Chemical compound COC1=C(O)C(OC)=CC(\C=N\N=C\C=2C=C(OC)C(O)=C(OC)C=2)=C1 YARKTHNUMGKMGS-LQGKIZFRSA-N 0.000 description 1
- 238000001311 chemical methods and process Methods 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 229960002173 citrulline Drugs 0.000 description 1
- 235000013477 citrulline Nutrition 0.000 description 1
- 239000004927 clay Substances 0.000 description 1
- 239000007891 compressed tablet Substances 0.000 description 1
- 239000012050 conventional carrier Substances 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- FSEUPUDHEBLWJY-HWKANZROSA-N diacetylmonoxime Chemical compound CC(=O)C(\C)=N\O FSEUPUDHEBLWJY-HWKANZROSA-N 0.000 description 1
- 238000002405 diagnostic procedure Methods 0.000 description 1
- ZBCBWPMODOFKDW-UHFFFAOYSA-N diethanolamine Chemical compound OCCNCCO ZBCBWPMODOFKDW-UHFFFAOYSA-N 0.000 description 1
- XTDYIOOONNVFMA-UHFFFAOYSA-N dimethyl pentanedioate Chemical compound COC(=O)CCCC(=O)OC XTDYIOOONNVFMA-UHFFFAOYSA-N 0.000 description 1
- 238000007598 dipping method Methods 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 238000001506 fluorescence spectroscopy Methods 0.000 description 1
- 125000002485 formyl group Chemical class [H]C(*)=O 0.000 description 1
- 230000001434 glomerular Effects 0.000 description 1
- 229930195712 glutamate Natural products 0.000 description 1
- 229940109738 hematin Drugs 0.000 description 1
- 229940025294 hemin Drugs 0.000 description 1
- 150000003840 hydrochlorides Chemical class 0.000 description 1
- 238000005470 impregnation Methods 0.000 description 1
- RSAZYXZUJROYKR-UHFFFAOYSA-N indophenol Chemical compound C1=CC(O)=CC=C1N=C1C=CC(=O)C=C1 RSAZYXZUJROYKR-UHFFFAOYSA-N 0.000 description 1
- 230000002452 interceptive effect Effects 0.000 description 1
- 230000003907 kidney function Effects 0.000 description 1
- 238000012933 kinetic analysis Methods 0.000 description 1
- 238000011005 laboratory method Methods 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 239000008176 lyophilized powder Substances 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 239000003094 microcapsule Substances 0.000 description 1
- 239000007932 molded tablet Substances 0.000 description 1
- JDEJGVSZUIJWBM-UHFFFAOYSA-N n,n,2-trimethylaniline Chemical compound CN(C)C1=CC=CC=C1C JDEJGVSZUIJWBM-UHFFFAOYSA-N 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 125000002524 organometallic group Chemical group 0.000 description 1
- 239000003973 paint Substances 0.000 description 1
- 235000021317 phosphate Nutrition 0.000 description 1
- 230000036211 photosensitivity Effects 0.000 description 1
- 229920002647 polyamide Polymers 0.000 description 1
- 229920002223 polystyrene Polymers 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 235000007686 potassium Nutrition 0.000 description 1
- 229910000028 potassium bicarbonate Inorganic materials 0.000 description 1
- 235000015497 potassium bicarbonate Nutrition 0.000 description 1
- 239000011736 potassium bicarbonate Substances 0.000 description 1
- TYJJADVDDVDEDZ-UHFFFAOYSA-M potassium hydrogencarbonate Chemical compound [K+].OC([O-])=O TYJJADVDDVDEDZ-UHFFFAOYSA-M 0.000 description 1
- 159000000001 potassium salts Chemical class 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 230000022558 protein metabolic process Effects 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- UIIMBOGNXHQVGW-UHFFFAOYSA-M sodium bicarbonate Substances [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 230000003595 spectral effect Effects 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 229920003002 synthetic resin Polymers 0.000 description 1
- 239000000057 synthetic resin Substances 0.000 description 1
- ZXQVPEBHZMCRMC-UHFFFAOYSA-R tetraazanium;iron(2+);hexacyanide Chemical compound [NH4+].[NH4+].[NH4+].[NH4+].[Fe+2].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-] ZXQVPEBHZMCRMC-UHFFFAOYSA-R 0.000 description 1
- 229960003495 thiamine Drugs 0.000 description 1
- 235000019157 thiamine Nutrition 0.000 description 1
- KYMBYSLLVAOCFI-UHFFFAOYSA-N thiamine Chemical compound CC1=C(CCO)SCN1CC1=CN=C(C)N=C1N KYMBYSLLVAOCFI-UHFFFAOYSA-N 0.000 description 1
- 239000011721 thiamine Substances 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 239000002023 wood Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/58—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving urea or urease
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- Physics & Mathematics (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Biophysics (AREA)
- Analytical Chemistry (AREA)
- Immunology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Enzymes And Modification Thereof (AREA)
Description
ç£æ¥äžã®å©çšåé
æ¬çºæã¯ãäžè¬ã«èšºæçšçµæç©ã詳述ããã°ã
æ¶²äœãç¹ã«è¡æ¶²åã³å°¿äžã®å°¿çŽ ã®å®æ§åã³å®éç
枬å®ã«æçšãªèšºæè©Šéšã«é¢ããã åŸæ¥ã®æè¡ å°¿çŽ ã¯ããåã³ä»ã®åºä¹³åç©ã«ãããèçœè³ªä»£
è¬ã®äž»ãªæçµçæç©ã§ããããã®çæç©ã¯ãèè
äžã§åœ¢æãããè¡æ¶²äžã«å ¥ããè èãéã€ãŠå°¿äž
ã«ææ³ãããå°¿äžã§ååšããææ©ç©è³ªã®äž»ãã©ã¯
ã·ãšã³ãæããçªçŽ è¡çãšèšããããè¡äžå°¿çŽ ã
éå°ã«ååšããç¶æ ã¯ã»ãšãã©åžžã«è èæ©èœãæ
ãªããè¡äžå°¿çŽ ïŒç±³åœã§ã¯éåžžãå°¿çŽ æ§çªçŽ ãšèš
ãããïŒã¯ãæãæ®éã«è¡ãããèšåºååŠè©Šéšã®
äžã€ã§ãããå°¿çŽ ãã¯ãªã¢ã©ã³ã¹ãåã¯è èã«ã
ãè¡æ¶²ããã®å°¿çŽ ã®é€å»çã¯ãå°¿äžã®å°¿çŽ æ¿åºŠã«
ãã€ãŠæž¬å®ããã糞çäœéé床ã®å°ºåºŠãšããŠäœ¿
çšãããã çç©åŠçæ¶²äœäžã®å°¿çŽ æ¿åºŠã枬å®ãããã䜿çš
ãããåžžçšã®èšåºååŠçæ¹æ³ã¯ã枬å®ãããè²å
äœã圢æãããé©åœãªè©Šè¬ãšå°¿çŽ ãšã®çž®åã«ãã
çŽæ¥æ³ãåã¯å°¿çŽ ã«å¯ŸããŠãŠã¬ã¢ãŒãŒãäœçšãã
ãŠçããçæç©ãšããŠã®ã¢ã³ã¢ãã¢ã®æž¬å®ã«ãã
鿥æ³ãšããŠåé¡ãããã ãžã¢ã»ãã«ã¢ããªãã·ã ã䜿çšããçŽæ¥æ³ã¯ã
ãã³ãªã€ïŒR.J.HenryïŒãèãã¯ãªãã«ã«ã»ã±ã
ã¹ããªã€âããªã³ã·ãã«ãºã»ã¢ã³ãã»ãã¯ãã¯ã¹
ïŒClinical ChemistryâPrinciples and
TechnicsïŒãããŒããŒã»ã¢ã³ãã»ããŒïŒHarper
ïŒRowïŒã第ïŒçïŒ1974幎ïŒã«èšèŒãããŠããã
äººçºæäœåã³èªåæäœã«ããéåžžã®èšåºååŠã«åº
ãé©çšãããŠããããã®æ¹æ³ã¯å€ãã®æ¬ ç¹ãæã
ããå³ã¡ããã·ãã«ãªã³ããã¢ã©ã³ãã€ã³åã³ä»ã®
äœæ¶²æåãšã®åŠšå®³åå¿ã«ããéç¹ç°æ§ã§ããã
ãšãæšæºæ²ç·åã¯ïŒç¹æ€éç·ãæ¯æ¥äœæããå¿ èŠ
ãããããšãæå æ§ã«ããè²ãæ¥éã«æ¶å€±ããã
ãšäžŠã³ã«æäœäžã®åé¡ç¹ãäŸãã°é«æž©ãå¿ èŠãšã
ãããšãèãåºæ¿èããããšããæ¬ ç¹ãæããã
ãããã®çç±ã§ã鿥çé µçŽ æ³ãäžè¬ã«å¥œãŸããŠ
ããã 鿥æ³ã¯ãäžèšã®åŒã«ãããŠã¬ã¢ãŒãŒïŒå°¿çŽ ã¢
ãããããã©ãŒãŒãEC3.5.1.5ïŒã«ããå°¿çŽ ã®ã¢
ã³ã¢ãã¢ãžã®é µçŽ å€æã«åºã¥ããã®ã§ããïŒ éé¢ããã¢ã³ã¢ãã¢ããã®åŸãé©åœãªè©Šè¬ç³»ã§æž¬
å®ããããªãã¿ãŒãªããïŒR.RichterichïŒèã
ãã¯ãªãã«ã«ã»ã±ãã¹ããªã€âã»ãªãªã€ã»ã¢ã³
ãã»ãã©ã¯ãã€ã¹ïŒClinical Chemistryâ
Theory and PracticeïŒãããã€ãèªã®ç¬¬ïŒçãã
翻蚳ãããŒãŒã«ã®ã«ãŒã²ã«ïŒS.KargerïŒïŒ1969ïŒ
åã³ãã«ã¯ãã€ã€ãŒïŒH.U.BergmeyerïŒèããã¡
ãœãã ã»ãªãã»ãšã³ãã€ããã€ãã¯ã»ã¢ããªã·ã¹
ïŒMethods of Enzymatic AnalysisïŒããè±èªã®ç¬¬
ïŒçãïŒå·»ãããŠãŒãšãŒã¯ã®ããšã«ã©ãŒã¯ã»ãã
ãŒâã¢ã«ãããã¯ã»ãã¬ã¹ïŒVerlag Chemieâ
Academic PressïŒïŒ1974ïŒããå°¿çŽ ã ãããŠã¬ã¢
ãŒãŒã«ãã€ãŠå æ°Žåè§£ãããã®ã§ãç¹ç°æ§ã¯é µçŽ
æ³ã®äž»ãªå©ç¹ã§ããã æãæ®åããŠããå®éšå®€æ³ã¯ãã¢ã³ã¢ããŠã ã€
ãªã³ãã¢ã«ã«ãªæ§åªäœäžã§ããšããŒã«åã³æ¬¡äºå¡©
çŽ é žå¡©ãšåå¿ããŠéè²å¡æã§ããã€ã³ãããšããŒ
ã«ãçæãããã«ãããŒãïŒBerthelotïŒåå¿ã«
åºã¥ããã®ã§ããããã®æ¹æ³ã«ãã€ãŠå°¿çŽ ãæž¬å®
ããã«ã¯ãäžèšã®ïŒã€ã®å·¥çšãå¿ èŠã§ãããå³
ã¡ã第äžå·¥çšã«ãããŠã詊æãé µçŽ åå¿ã«æãé©
åœãªPHïŒå³ã¡ãçŽ6.5ïŒã§ãŠã¬ã¢ãŒãŒãšå ±ã«37â
ã§ïŒéåžž10ã20åïŒé眮ãã第äºå·¥çšã§ãããšã
ãŒã«åã³æ¬¡äºå¡©çŽ é žå¡©ã®ã¢ã«ã«ãªæ§æº¶æ¶²ãæ·»å
ããçºè²ããããããéåžž37âã§10ã30åé眮ã
ãã ãã«ã¯ãã€ã€ãŒã®åæ²æç®ã«ã¯ãå¥ã®æ¹æ³ãèš
èŒãããŠããããã®æ¹æ³ã§ã¯ãåŒïŒ ïŒâãªããœã°ã«ã¿ã¬ãŒãïŒNADHïŒNH4 + GIDH ââââââ âã°ã«ã¿ã¡ãŒãïŒNAD+ïŒH2O ã«ããããŠã¬ã¢ãŒãŒãšã®é µçŽ åå¿ããèªå°ããã
ã¢ã³ã¢ããŠã ã€ãªã³ãé µçŽ ã§ããã°ã«ã¿ãã³é žã
ãããã²ããŒãŒïŒGIDHïŒã§æž¬å®ãã340ããã¡
ãŒã¿ïŒïœïœïŒïŒåã¯334åã¯366nïœïŒã§ã®éå ã
ãããã³ãã³ã¢ããã¢ããã³ãžãã¯ã¬ãªãã
ïŒNADHïŒã®åžå 床ã®äœäžã枬å®ããããã®æ¹æ³
ã§ã¯ãïŒå·¥çšåã³ïŒè©Šè¬è£œå€ãçšããåæ åæãš
ããŠäœ¿çšããããã«ãçš®ã ã«å€æŽããããããã
ã®æ¹è¯ã«ããããããã詊è¬ãé«äŸ¡ã§ãããèªå
çé£ç¶æµåæè£ 眮ãžã®é©çšæ§ã«æ¬ ããŠããã®ã§ã
éåžžã®èšåºååŠã«ããããã®æ¹æ³ã®äœ¿çšã¯éãã
ãŠããã ç±³åœç¹èš±ç¬¬4194063å·æçŽ°æžã«ã¯ããŠã¬ã¢ãŒãŒ
ã®äœçšã«ãã€ãŠå°¿çŽ ããéé¢ãããã¢ã³ã¢ãã¢ã
ã¢ã«ãããã®ååšã§Î²âãžã±ãã³ãšã®çž®åã«ãã
æ€åºããçããè²ãåå å 床åæåã¯è¢å åå å
ææ³ã«ããç£èŠããããšã«ããå°¿çŽ ãæž¬å®ããçµ
æç©åã³æ¹æ³ãèšèŒãããŠããããã®æ¹æ³ã¯ïŒå·¥
çšæ³ã§ã¯ããããé·ãé眮æéãèŠãããåã¯å
ççæéã§åæãè¡ãã«ã¯é«ãåå¿æž©åºŠãå¿ èŠãš
ããã ã«ãŒã³ïŒR.J.RoonïŒåã³ããŒãŠãšã³ãã«ã¯
ïŒB.LowenbergïŒã¯ãã¡ãœãã ã»ã€ã³ã»ãšã³ãã€
ã¢ããžã€ïŒMethods in EnzymologyïŒããã³ããŠ
ã€ã¯ïŒColowickïŒïŒã«ãã©ã³ïŒKaplanïŒç·šéã
ã¢ã«ãããã¯ã»ãã¬ã¹ïŒAcademic PressïŒã
ã317é ïŒ1970ïŒã«ãå°¿çŽ ã¢ãããªã¢ãŒãŒ
ïŒEC3.5.1.45ïŒã®è£œé åã³æ§è³ªãèšèŒãããã«ãŒ
ã³æ³ã¯ãå°¿çŽ ã¢ãããªã¢ãŒãŒè£œå€ã®æŽ»æ§ãåæã
ãããèšç»ããããã®ã§ããã¹ããšããŒã«ãã«ã
ãŒãããã«ãã³é žãããŒãŒåã³ä¹³é žããããã²ã
ãŒãŒã䜿çšããã¢ããã·ã³äºãªã³é žïŒADPïŒã
åå å 床åæã«ããæž¬å®ããDPHNïŒåæ
NADHïŒã®é žåã«ããèµ·ããåžå åºŠã®æžå°ãç£
èŠãããã®ã§ãããã«ãŒã³ã®æ¹æ³ã«ãã€ãŠå®æœã
ããå°¿çŽ ã®åæã¯ã°ã«ã¿ãã³é žããããã²ããŒãŒ
ã«ããåŸæ¥ã®UVæ³ã«æ¯ã¹ãŠå©ç¹ããããããã®
ã§ã¯ãªããäºå®ãé¢ä¿ããåå¿ã®ååŠéè«ã«ã
ããã«ãŒã³æ³ã¯ã°ã«ã¿ãã³é žããããã²ããŒãŒæ³
ã®ååã®æåºŠãæããã«ãããªãã æ±æŽéžé ã«è²æž¡ãããŠããç±³åœç¹èš±ç¬¬4246342
å·æçŽ°æžã¯ããã«ãã³é žå¡©ã枬å®ããåææ³ãé
瀺ããADPããŸããã¹ããšããŒã«ãã«ããŒãå
ã³ãã«ãã³é žãããŒãŒãšåå¿ãããŠãã«ãã³é žå¡©
ãçæãããã°ãADPããã«ãã³é žå¡©æ³ã«ãã€
ãŠæž¬å®ãããããšã瀺åããŠããã å°¿çŽ ã¢ãããªã¢ãŒãŒã®äœ¿çšã«åºã¥ãå°¿çŽ ã®é µçŽ
åæããéæãªæ¯è²ïŒå·¥çšåæãå¯èœã«ãããŠã¬
ã¢ãŒãŒãå©çšããåŸæ¥æ³ããåäžããçµæãçã
ãæ¹æ³ã«ãã€ãŠå®æãããããšãèŠãåºããã çºæã®æŠèŠ æ¬çºæã®ç®çã¯ãå¯èŠã¹ãã¯ãã«ç¯å²ã«èªã¿å
ãææšãæããïŒå·¥çšåå¿ãšããŠãéåžžã®äœ¿çšã«
䟿å©ã§ãèªåè£ çœ®ã«é©åããããä¿¡é Œæ§ã®é«ãå°¿
çŽ è©ŠéšãæäŸããããšã§ãããå°¿çŽ ã¢ãããªã¢ãŒ
ãŒããã«ãã³é žãããŒãŒããã«ãã³é žãªãã·ããŒ
ãŒãïŒäŸ¡åã³ïŒäŸ¡ã®éœã€ãªã³ãããã¹ããšããŒã«
ãã«ããŒãããã¢ãã³ãããªã³é žãã¢ããã·ã³äž
ãªã³é žãéçé žå¡©ãçºè²æç€ºè¬ç³»äžŠã³ã«å Žåã«ã
ãç¡æ©ãªã³é žå¡©ãçŽ6.5ã9.5ã®PHç¯å²ãæããç·©
è¡å€åã³ããšãã·ã¢ã³åãããªãŠã åã¯ã«ãªãŠã
ãæ¶²äœè©Šæäžã®å°¿çŽ ãæ€åºãããã䜿çšããããš
ãæ¬çºæã®ç®çã§ãããå°¿åã³è¡æ¶²ïŒè¡æŒ¿åã¯è¡
æž ïŒã®ãããªäœæ¶²ãå«ããŠæ¶²äœè©Šæäžã®å°¿çŽ ã®æ€
åºçšã®çµæç©ãæ€åºå ·åã³æ€åºæ¹æ³ãæäŸããã
ãã®çµæç©ã¯å°¿çŽ ã¢ãããªã¢ãŒãŒããã«ãã³é žã
ããŒãŒããã«ãã³é žãªãã·ããŒãŒãïŒäŸ¡éœã€ãª
ã³ã奜ãŸããã¯Mg++ãïŒäŸ¡éœã€ãªã³ã奜ãŸãã
ã¯K+ããã¹ããšããŒã«ãã«ããŒãããã¢ãã³ã
ããªã³é žãã¢ããã·ã³äžãªã³é žïŒATPïŒäžŠã³ã«
éé žåæ°ŽçŽ ãçæãããçé žå¡©åã³çºè²æç€ºè¬
ç³»ã奜ãŸããã¯ãã«ãªãã·ããŒãŒãïŒâã¢ããã
ãšããŸã³åã³ããšããŒã«åã¯çœ®æããšããŒã«ãäŸ
ãã°ïœâããããã·ãã³ãŒã³ã¹ã«ãã³é žåã¯ïŒâ
ããããã·ããšãã«é ¢é žãå«ããçµæç©ã¯ç¡æ©ãª
ã³é žå¡©ãå«ãã®ã奜ãŸããã ãå¯éçãæç€ºè¬ãäŸãã°ïœâãžã¢ãã·ãžã³ã
ããã©ã¡ãã«ãã³ãžãžã³ããã€ã³ææçã䜿çšã
ãããšã«ãã€ãŠéé žåæ°ŽçŽ ã®æ€åºã宿œããããš
ãã§ããããããã«ããŠããçºè²ãå ã®å°¿çŽ æ¿åºŠ
ã«çžé¢ãããããšã«ãã€ãŠæ¯è²æ³ã«ãã€ãŠå®éã
è¡ãã 奜ãŸããã¯çŽ6.5ãçŽ9.5ã®PHã«ç·©è¡ããïŒæäœ
溶液ãšããŠäœ¿çšããããåæ§æããããåã¯æ äœ
ã«æ··å ¥ããŠè©Šéšå ·ãäŸãã°é å€åã¯è©Šè¬ãããªã
ã¯ã¹ãäœãããšã®ã§ãããããããã®åã§çµæç©
ãæäŸããããšãã§ããã æ¬çºæã¯è¥å¹²ã®å©ç¹ãå³ã¡(1)äžã€ã®æäœè©Šè¬ã
䜿çšããŠäŸ¿å©ãªïŒå·¥çšåå¿ãçããã(2)å¯èŠç¯å²
ã®èªã¿åãææšãçããã®ã§ã玫å€ç·èªã¿åãæ
æšã«å¿ èŠãªé«äŸ¡ãªè£ 眮ã¯äžèŠã§ããã(3)ãã®ç³»ã§
èµ·ããåå¿ã¯ã髿ž©åå¿ã§ãªãåã³(4)ãã®æäœã
èªåè£ çœ®ã«å®¹æã«é©åãããããšããå©ç¹ãåã
ãæãããã®ã§ãã€ãŠãéåžžã®äœ¿çšã«é©åãªãã®
ã§ããã æ¬çºæãæŽã«ååã«çè§£ããããã以äžã«æŽã«
詳述ããã 奜ãŸãã宿œæ æ§ã®èª¬æ æ¬çºæã¯å°¿çŽ ã®é µçŽ åæã«ãããå°¿çŽ ã¢ãããª
ã¢ãŒãŒã®äœ¿çšã«åºã¥ããæ¬çºæã«ããçµæç©ã¯ã
æ¶²äœè©Šæäžã®å°¿çŽ ã®ååšã«å¿ããŠãéé žåæ°ŽçŽ ã
çæããé µçŽ ææ®µåã³éé žåæ°ŽçŽ ã«å¿çããŠãè²
ã®å¿çãçããçºè²æç€ºè¬ç³»ãå«ããå°¿çŽ å¿çæ
段ã¯å°¿çŽ ã¢ãããªã¢ãŒãŒïŒE.C.3.5.1.45ïŒããã«ã
ã³é žãããŒãŒïŒE.C.2.7.1.40ïŒåã³ãã«ãã³é žãª
ãã·ããŒãŒïŒE.C.1.2.3.3ïŒãå«ããæŽã«ãã¢ãã
ã·ã³â5â²âäžãªã³é žïŒATPïŒãéçé žå¡©ãéœã€ãª
ã³ããã¹ããšããŒã«ãã«ããŒãïŒPEPïŒåã³ã
ã¢ãã³ãããªã³é žãå¿ èŠã§ããã çµæç©ã«ç¡æ©ãªã³é žå¡©ãæ·»å ããã®ã奜ãŸã
ãã åå¿åŒã¯äžèšã®ãšããã§ããïŒ (1) å°¿çŽ ïŒHCO3 -ïŒATDå°¿çŽ ã¢ãããªã¢ãŒãŒ âââââââââââââââ ïŒäŸ¡åã¯ïŒäŸ¡éœã€ãªã³2NH3ïŒPiïŒ2CO2ïŒADP (2) ADPïŒãã¹ããšããŒã«ãã«ããŒããã«ãã³é žãããŒ
㌠âââââââââââââââ ïŒäŸ¡éœã€ãªã³ãã«ãã³é žå¡©ïŒATP (3) ãã«ãã³é žå¡©ïŒPiïŒO2ãã«ãã³é žãªãã·ã¿ãŒãŒ âââââââââââââââ ãã¢ãã³ãããªã³é žã¢ã»ãã«ãã¹ããšãŒãïŒCO2ïŒH2O2 çæããéé žåæ°ŽçŽ ãæ¬¡ã«çºè²æç€ºè¬ç³»ã䜿çš
ããŠæž¬å®ããããšãã§ããã çºè²æç€ºè¬ç³»ã¯ãäžèšã®åå¿ã«ããããã«ãªã
ã·ããŒãŒãïŒâã¢ããããšããŸã³åã³ããšããŒã«
åã¯çœ®æããšããŒã«ãäŸãã°ïŒâããããã·ããš
ãã«é ¢é žãå«ãã®ã奜ãŸããïŒ (4) çºè²æç€ºè¬æå ïŒH2O2ãã«ãªãã·ã¿ãŒãŒ ââââââââââââ è²çŽ åœ¢æããè²çŽ ã¯éé žåæ°ŽçŽ ãåŸã€ãŠãå°¿çŽ ã®æ¿
åºŠã«æ¯äŸãããåŸã€ãŠãæ¯è²èšåã¯å 床èšãçšã
ãŠå¯èŠç¯å²ãäžè¬ã«400ã700nïœã§åå¿ããæº¶æ¶²
ã®åžå åºŠãæž¬å®ããã ãã§ãå°¿çŽ ã®æ¿åºŠã枬å®ã
ãããšãã§ããã ä»»æã®æå®ã®æéã«çããè²çŽ ã®éãå°¿çŽ ã®æ¿
åºŠã«æ¯äŸããã®ã§ãçµç¹æ³åã¯é床æ³ã䜿çšãã
ããšãã§ããã é µçŽ ã§ããå°¿çŽ ã¢ãããªã¢ãŒãŒã¯ãçš®ã ã®åŸ®ç
ç©ããåŸããããBiol.Chem.ã274ã4107ã4113
ïŒ1972ïŒåç §ã䜿çšããä»ã®é µçŽ ã¯åžè²©ãããŠã
ãã ïŒäŸ¡ã®éœã€ãªã³ãšããŠãMg++åã¯Mn++ã䜿
çšãããããMg++ã奜ãŸãããïŒäŸ¡éœã€ãªã³ã¯
K+ãNH4 +ãRb+åã¯Cs+ã®çŸ€ããéžæãããã
K+ã奜ãŸããã éçé žã€ãªã³æºãšããŠãä»»æã®é©åã«å¯æº¶æ§ã®
éçé žå¡©ãäŸãã°ã¢ã«ã«ãªéå±å¡©åã¯ã¢ã«ã«ãªå
é¡éå±å¡©ã䜿çšããããšãã§ãããéçé žãããª
ãŠã åã¯ã«ãªãŠã ã奜ãŸãããç¡æ©ãªã³é žæºãäŸ
絊ãããããåæ§ã®å¡©ã䜿çšããããšãã§ããã æ¬çºæã«æçšãªéé žåç©æŽ»æ§ãæããç©è³ªã¯ã
çš®ã ã®ææ©åã³ç¡æ©ç©è³ªæºããéžæããããšãã§
ãããçš®ã ã®æ€ç©ãã«ãªãã·ããŒãŒãäŸãã°è¥¿æŽ
ããã³åã¯ãã¬ã€ã·ãšãã«ãªãã·ããŒãŒã䜿çšã
ãããšãã§ãããæŽã«ãããŸã奜ãŸããã¯ãªã
ãããããã³åã³ããã³èªå°äœããã¢ã°ããã³å
ã³ãããã³ã䜿çšããããšãã§ããã äžã€ã®é©åœãªçºè²æç€ºè¬ç³»ã¯ãéé žåç©æŽ»æ§æ
åã奜ãŸããã¯ãã«ãªãã·ããŒãŒãåã³çºè²æç€º
è¬æåã®åå¿ãçµåããããã«ãªãã·ããŒãŒãšå ±
ã«äœ¿çšãããçºè²æç€ºè¬æåã¯ããå¯éçãæç€º
è¬ãäŸãã°ïœâãžã¢ãã·ãžã³ãããã©ã¡ãã«ãã³
ãžãžã³ããã€ã³ææãïŒïŒ2â²âã¢ãžã³âãžïŒãšã
ã«ãã³ãŸãã¢ãŸãªã³âïŒâã¹ã«ãã³é žïŒãã·ãªã³
ã¬ã«ããžã³çãåã³é žåæ§ã«ãããªã³ã°æåãäŸ
ãã°ïŒâã¢ããããšããŸã³è¥ããã¯ãã®èªå°äœå
ã³ããšããŒã«åã¯ããããŒã«ãåã¯è³éŠæã¢ã
ã³ãåã¯ãããã®èªå°äœãåã¯ïŒâã¡ãã«ãã³ãŸ
ãã¢ãŸãªãã³ããã©ãŸã³ïŒMBTHïŒåã³ããšã
ãŒã«åã¯ããããŒã«ãåã¯è³éŠæã¢ãã³åã¯ãã
ãã®èªå°äœãå å«ããã åŸæ¥å ¬ç¥ã®é©åã«çœ®æããã倿°ã®ããšããŒã«
ããæ¬çºæã«äœ¿çšããããšãã§ããããã®ãããª
眮æããšããŒã«ã®äŸã¯ãã¡ã€ãã¿ãïŒMeittaniïŒ
ã®ç±³åœç¹èš±ç¬¬3886045å·æçŽ°æžïŒç±³åœç¹èš±ç¬¬
Re29498å·ãšããŠåçºè¡ãããŠããïŒã«é瀺ãã
ãŠããã®ã§ããããåèæç®ãšããŠæ¬æçްæžã«å«
ããã奜ãŸãã眮æããšããŒã«ã¯ïŒâããããã·
ããšãã«é ¢é žã§ãããæŽã«ãïŒâãïŒâåã³ïŒâ
ããããã·ãã³ãžã«ã¢ã«ã³ãŒã«ãïœâãïœâåã³
ïœâããããã·ãã³ãŒã³ã¹ã«ãã³é žãïŒâã¯ãã
âïŒïŒïŒâã¡ãã«ããšããŒã«åã³ïŒâããããã·
âïŒâã¯ãããã³ãŒã³ã¹ã«ãã³é žã䜿çšããããš
ãã§ãããé©åœãªããããŒã«ã¯ãäŸãã°ïŒâãã
ããŒã«ãïŒâããããŒã«ãïŒâããããã·âïŒâ
ããããšé žåã³ãããã®ã¹ã«ãã³åèªå°äœã§ã
ããé©åœãªè³éŠæã¢ãã³ã¯ãäŸãã°ïŒ®ïŒïŒ®âãžã¡
ãã«âåã³ïŒ®ïŒïŒ®âãžãšãã«âã¢ããªã³ãïŒïŒ®
âãžã¡ãã«âïœâãã«ã€ãžã³ãïŒïŒ®âãžããã
ãã·ãšãã«âïœâåã¯âïœâãã«ã€ãžã³åã³ïŒâ
ïŒïŒ®âãžã¡ãã«ã¢ãã宿¯éŠé žã§ãããåèšå
åç©ã®å¯æº¶æ§å¡©ãäŸãã°ããšããŒã«ãããããŒã«
ã«ã¯ãããªãŠã å¡©åã¯ã«ãªãŠã å¡©ãã¢ãã³é¡ã«ã¯
å¡©é žå¡©ã䜿çšããããšãã§ããã å¥ã®é©åœãªçºè²æç€ºè¬ç³»ã¯ãã¢ã³ã¢ããŠã ã€ãª
ã³åã³Î²âãžã±ãã³ãšã®åå¿ã«ãããžãããã«ã
ãžã³èªå°äœã圢æããåå¿ã«ãããåã¯ïŒâã¢ã
ãâïŒâããã©ãžãâïŒâã¡ã«ã«ããâïŒïŒïŒïŒ
ïŒâããªã¢ãŸãŒã«è¥ããã¯ãã«ã ã¢ã«ããããšçž®
åããŠè²çŽ ãçæãããä»ã®ç©è³ªãšã®åå¿ã«ãã
ã¡ã¿ããŒã«ã®ååšã§çæãããã«ã ã¢ã«ãããã
ç£èŠããããšã«ãã€ãŠã«ã¿ã©ãŒãŒãå©çšããã æåŸã«ãææ©éå±é¯äœãäŸãã°ãã¿ããŠã
ïŒïŒâïŒïŒïŒâããªãžã«ã¢ãŸïŒã¬ãŸã«ã·ããŒã«å
ã¯ãã¿ããŠã ïŒïŒâãã·ã¬ããŒã«ãªã¬ã³ãžã®é ž
åã«ãããé µçŽ ãçšããªãã§è²çŽ ãçæããããš
ãã§ããã äœæ¶²è©Šæäžã®ããªã«ãã³ã®åŠšå®³ãäœæžããããš
ã«ãã€ãŠåæã®ç¹ç°æ§ãå¢å ãããããçš®ã ã®ã¢
ã«ã«ãªéå±ããšãã·ã¢ã³åç©ãäŸãã°ããšãã·ã¢
ã³åã«ãªãŠã ããããªãŠã åã³ã«ã«ã·ãŠã ã䜿çš
ããããšãã§ãããããšãã·ã¢ã³åç©æºãšããŠã
ããšãã·ã¢ã³åã¢ã³ã¢ããŠã åã³ããšãã·ã¢ã³å
ç©çæååç©ã䜿çšããããšãã§ããã å·¥çšå šäœãå¡©åºåã¯é žã§ç·©è¡ããç³»äžã§è¡ãã
é©åœãªç·©è¡å€ã¯ããªã³é žå¡©ãâïŒâããããã·
ãšãã«ããã©ãžã³âNâ²âïŒâãšã¿ã³ã¹ã«ãã³é ž
ïŒHEPESïŒãïŒâïŒïŒ®âã¢ã«ããªãïŒãããã³ã¹
ã«ãã³é žïŒMOPSïŒãããªã¹ïŒããããã·ã¡ã
ã«ïŒâã¢ããã¡ã¿ã³ïŒTRISïŒãâããªã¹ïŒãã
ããã·ã¡ãã«ïŒâã¡ãã«âïŒâã¢ãããšã¿ã³ã¹ã«
ãã³é žïŒTESïŒãâïŒâããããã·ãšãã«ãã
ã©ãžã³ãããã³ã¹ã«ãã³é žïŒEPPSïŒããžãšã¿ã
ãŒã«ã¢ãã³åã³ã°ã«ã¿ã«é žãžã¡ãã«ã§ããã æŽã«ãå®å®åå€ã®ãããªç©è³ªåã³ä»ã®åžžçšã®æ·»
å ç©ãå¿ èŠã«å¿ããŠäœ¿çšããããšãã§ãããçµæ
ç©ã溶å€ãäŸãã°æ°ŽãççåŠç溶液åã¯ææ©æº¶
å€ãäŸãã°ã¡ã¿ããŒã«åã¯ãããã®æ··åç©ãçšã
ãŠè£œé ããæº¶æ¶²ã®åœ¢ã§äœ¿çšããããšãã§ããã æå¹ãªæ¿åºŠç¯å²åã³å¥œé©æ¿åºŠç¯å²ã以äžã«ç€º
ãïŒ
æ¶²äœãç¹ã«è¡æ¶²åã³å°¿äžã®å°¿çŽ ã®å®æ§åã³å®éç
枬å®ã«æçšãªèšºæè©Šéšã«é¢ããã åŸæ¥ã®æè¡ å°¿çŽ ã¯ããåã³ä»ã®åºä¹³åç©ã«ãããèçœè³ªä»£
è¬ã®äž»ãªæçµçæç©ã§ããããã®çæç©ã¯ãèè
äžã§åœ¢æãããè¡æ¶²äžã«å ¥ããè èãéã€ãŠå°¿äž
ã«ææ³ãããå°¿äžã§ååšããææ©ç©è³ªã®äž»ãã©ã¯
ã·ãšã³ãæããçªçŽ è¡çãšèšããããè¡äžå°¿çŽ ã
éå°ã«ååšããç¶æ ã¯ã»ãšãã©åžžã«è èæ©èœãæ
ãªããè¡äžå°¿çŽ ïŒç±³åœã§ã¯éåžžãå°¿çŽ æ§çªçŽ ãšèš
ãããïŒã¯ãæãæ®éã«è¡ãããèšåºååŠè©Šéšã®
äžã€ã§ãããå°¿çŽ ãã¯ãªã¢ã©ã³ã¹ãåã¯è èã«ã
ãè¡æ¶²ããã®å°¿çŽ ã®é€å»çã¯ãå°¿äžã®å°¿çŽ æ¿åºŠã«
ãã€ãŠæž¬å®ããã糞çäœéé床ã®å°ºåºŠãšããŠäœ¿
çšãããã çç©åŠçæ¶²äœäžã®å°¿çŽ æ¿åºŠã枬å®ãããã䜿çš
ãããåžžçšã®èšåºååŠçæ¹æ³ã¯ã枬å®ãããè²å
äœã圢æãããé©åœãªè©Šè¬ãšå°¿çŽ ãšã®çž®åã«ãã
çŽæ¥æ³ãåã¯å°¿çŽ ã«å¯ŸããŠãŠã¬ã¢ãŒãŒãäœçšãã
ãŠçããçæç©ãšããŠã®ã¢ã³ã¢ãã¢ã®æž¬å®ã«ãã
鿥æ³ãšããŠåé¡ãããã ãžã¢ã»ãã«ã¢ããªãã·ã ã䜿çšããçŽæ¥æ³ã¯ã
ãã³ãªã€ïŒR.J.HenryïŒãèãã¯ãªãã«ã«ã»ã±ã
ã¹ããªã€âããªã³ã·ãã«ãºã»ã¢ã³ãã»ãã¯ãã¯ã¹
ïŒClinical ChemistryâPrinciples and
TechnicsïŒãããŒããŒã»ã¢ã³ãã»ããŒïŒHarper
ïŒRowïŒã第ïŒçïŒ1974幎ïŒã«èšèŒãããŠããã
äººçºæäœåã³èªåæäœã«ããéåžžã®èšåºååŠã«åº
ãé©çšãããŠããããã®æ¹æ³ã¯å€ãã®æ¬ ç¹ãæã
ããå³ã¡ããã·ãã«ãªã³ããã¢ã©ã³ãã€ã³åã³ä»ã®
äœæ¶²æåãšã®åŠšå®³åå¿ã«ããéç¹ç°æ§ã§ããã
ãšãæšæºæ²ç·åã¯ïŒç¹æ€éç·ãæ¯æ¥äœæããå¿ èŠ
ãããããšãæå æ§ã«ããè²ãæ¥éã«æ¶å€±ããã
ãšäžŠã³ã«æäœäžã®åé¡ç¹ãäŸãã°é«æž©ãå¿ èŠãšã
ãããšãèãåºæ¿èããããšããæ¬ ç¹ãæããã
ãããã®çç±ã§ã鿥çé µçŽ æ³ãäžè¬ã«å¥œãŸããŠ
ããã 鿥æ³ã¯ãäžèšã®åŒã«ãããŠã¬ã¢ãŒãŒïŒå°¿çŽ ã¢
ãããããã©ãŒãŒãEC3.5.1.5ïŒã«ããå°¿çŽ ã®ã¢
ã³ã¢ãã¢ãžã®é µçŽ å€æã«åºã¥ããã®ã§ããïŒ éé¢ããã¢ã³ã¢ãã¢ããã®åŸãé©åœãªè©Šè¬ç³»ã§æž¬
å®ããããªãã¿ãŒãªããïŒR.RichterichïŒèã
ãã¯ãªãã«ã«ã»ã±ãã¹ããªã€âã»ãªãªã€ã»ã¢ã³
ãã»ãã©ã¯ãã€ã¹ïŒClinical Chemistryâ
Theory and PracticeïŒãããã€ãèªã®ç¬¬ïŒçãã
翻蚳ãããŒãŒã«ã®ã«ãŒã²ã«ïŒS.KargerïŒïŒ1969ïŒ
åã³ãã«ã¯ãã€ã€ãŒïŒH.U.BergmeyerïŒèããã¡
ãœãã ã»ãªãã»ãšã³ãã€ããã€ãã¯ã»ã¢ããªã·ã¹
ïŒMethods of Enzymatic AnalysisïŒããè±èªã®ç¬¬
ïŒçãïŒå·»ãããŠãŒãšãŒã¯ã®ããšã«ã©ãŒã¯ã»ãã
ãŒâã¢ã«ãããã¯ã»ãã¬ã¹ïŒVerlag Chemieâ
Academic PressïŒïŒ1974ïŒããå°¿çŽ ã ãããŠã¬ã¢
ãŒãŒã«ãã€ãŠå æ°Žåè§£ãããã®ã§ãç¹ç°æ§ã¯é µçŽ
æ³ã®äž»ãªå©ç¹ã§ããã æãæ®åããŠããå®éšå®€æ³ã¯ãã¢ã³ã¢ããŠã ã€
ãªã³ãã¢ã«ã«ãªæ§åªäœäžã§ããšããŒã«åã³æ¬¡äºå¡©
çŽ é žå¡©ãšåå¿ããŠéè²å¡æã§ããã€ã³ãããšããŒ
ã«ãçæãããã«ãããŒãïŒBerthelotïŒåå¿ã«
åºã¥ããã®ã§ããããã®æ¹æ³ã«ãã€ãŠå°¿çŽ ãæž¬å®
ããã«ã¯ãäžèšã®ïŒã€ã®å·¥çšãå¿ èŠã§ãããå³
ã¡ã第äžå·¥çšã«ãããŠã詊æãé µçŽ åå¿ã«æãé©
åœãªPHïŒå³ã¡ãçŽ6.5ïŒã§ãŠã¬ã¢ãŒãŒãšå ±ã«37â
ã§ïŒéåžž10ã20åïŒé眮ãã第äºå·¥çšã§ãããšã
ãŒã«åã³æ¬¡äºå¡©çŽ é žå¡©ã®ã¢ã«ã«ãªæ§æº¶æ¶²ãæ·»å
ããçºè²ããããããéåžž37âã§10ã30åé眮ã
ãã ãã«ã¯ãã€ã€ãŒã®åæ²æç®ã«ã¯ãå¥ã®æ¹æ³ãèš
èŒãããŠããããã®æ¹æ³ã§ã¯ãåŒïŒ ïŒâãªããœã°ã«ã¿ã¬ãŒãïŒNADHïŒNH4 + GIDH ââââââ âã°ã«ã¿ã¡ãŒãïŒNAD+ïŒH2O ã«ããããŠã¬ã¢ãŒãŒãšã®é µçŽ åå¿ããèªå°ããã
ã¢ã³ã¢ããŠã ã€ãªã³ãé µçŽ ã§ããã°ã«ã¿ãã³é žã
ãããã²ããŒãŒïŒGIDHïŒã§æž¬å®ãã340ããã¡
ãŒã¿ïŒïœïœïŒïŒåã¯334åã¯366nïœïŒã§ã®éå ã
ãããã³ãã³ã¢ããã¢ããã³ãžãã¯ã¬ãªãã
ïŒNADHïŒã®åžå 床ã®äœäžã枬å®ããããã®æ¹æ³
ã§ã¯ãïŒå·¥çšåã³ïŒè©Šè¬è£œå€ãçšããåæ åæãš
ããŠäœ¿çšããããã«ãçš®ã ã«å€æŽããããããã
ã®æ¹è¯ã«ããããããã詊è¬ãé«äŸ¡ã§ãããèªå
çé£ç¶æµåæè£ 眮ãžã®é©çšæ§ã«æ¬ ããŠããã®ã§ã
éåžžã®èšåºååŠã«ããããã®æ¹æ³ã®äœ¿çšã¯éãã
ãŠããã ç±³åœç¹èš±ç¬¬4194063å·æçŽ°æžã«ã¯ããŠã¬ã¢ãŒãŒ
ã®äœçšã«ãã€ãŠå°¿çŽ ããéé¢ãããã¢ã³ã¢ãã¢ã
ã¢ã«ãããã®ååšã§Î²âãžã±ãã³ãšã®çž®åã«ãã
æ€åºããçããè²ãåå å 床åæåã¯è¢å åå å
ææ³ã«ããç£èŠããããšã«ããå°¿çŽ ãæž¬å®ããçµ
æç©åã³æ¹æ³ãèšèŒãããŠããããã®æ¹æ³ã¯ïŒå·¥
çšæ³ã§ã¯ããããé·ãé眮æéãèŠãããåã¯å
ççæéã§åæãè¡ãã«ã¯é«ãåå¿æž©åºŠãå¿ èŠãš
ããã ã«ãŒã³ïŒR.J.RoonïŒåã³ããŒãŠãšã³ãã«ã¯
ïŒB.LowenbergïŒã¯ãã¡ãœãã ã»ã€ã³ã»ãšã³ãã€
ã¢ããžã€ïŒMethods in EnzymologyïŒããã³ããŠ
ã€ã¯ïŒColowickïŒïŒã«ãã©ã³ïŒKaplanïŒç·šéã
ã¢ã«ãããã¯ã»ãã¬ã¹ïŒAcademic PressïŒã
ã317é ïŒ1970ïŒã«ãå°¿çŽ ã¢ãããªã¢ãŒãŒ
ïŒEC3.5.1.45ïŒã®è£œé åã³æ§è³ªãèšèŒãããã«ãŒ
ã³æ³ã¯ãå°¿çŽ ã¢ãããªã¢ãŒãŒè£œå€ã®æŽ»æ§ãåæã
ãããèšç»ããããã®ã§ããã¹ããšããŒã«ãã«ã
ãŒãããã«ãã³é žãããŒãŒåã³ä¹³é žããããã²ã
ãŒãŒã䜿çšããã¢ããã·ã³äºãªã³é žïŒADPïŒã
åå å 床åæã«ããæž¬å®ããDPHNïŒåæ
NADHïŒã®é žåã«ããèµ·ããåžå åºŠã®æžå°ãç£
èŠãããã®ã§ãããã«ãŒã³ã®æ¹æ³ã«ãã€ãŠå®æœã
ããå°¿çŽ ã®åæã¯ã°ã«ã¿ãã³é žããããã²ããŒãŒ
ã«ããåŸæ¥ã®UVæ³ã«æ¯ã¹ãŠå©ç¹ããããããã®
ã§ã¯ãªããäºå®ãé¢ä¿ããåå¿ã®ååŠéè«ã«ã
ããã«ãŒã³æ³ã¯ã°ã«ã¿ãã³é žããããã²ããŒãŒæ³
ã®ååã®æåºŠãæããã«ãããªãã æ±æŽéžé ã«è²æž¡ãããŠããç±³åœç¹èš±ç¬¬4246342
å·æçŽ°æžã¯ããã«ãã³é žå¡©ã枬å®ããåææ³ãé
瀺ããADPããŸããã¹ããšããŒã«ãã«ããŒãå
ã³ãã«ãã³é žãããŒãŒãšåå¿ãããŠãã«ãã³é žå¡©
ãçæãããã°ãADPããã«ãã³é žå¡©æ³ã«ãã€
ãŠæž¬å®ãããããšã瀺åããŠããã å°¿çŽ ã¢ãããªã¢ãŒãŒã®äœ¿çšã«åºã¥ãå°¿çŽ ã®é µçŽ
åæããéæãªæ¯è²ïŒå·¥çšåæãå¯èœã«ãããŠã¬
ã¢ãŒãŒãå©çšããåŸæ¥æ³ããåäžããçµæãçã
ãæ¹æ³ã«ãã€ãŠå®æãããããšãèŠãåºããã çºæã®æŠèŠ æ¬çºæã®ç®çã¯ãå¯èŠã¹ãã¯ãã«ç¯å²ã«èªã¿å
ãææšãæããïŒå·¥çšåå¿ãšããŠãéåžžã®äœ¿çšã«
䟿å©ã§ãèªåè£ çœ®ã«é©åããããä¿¡é Œæ§ã®é«ãå°¿
çŽ è©ŠéšãæäŸããããšã§ãããå°¿çŽ ã¢ãããªã¢ãŒ
ãŒããã«ãã³é žãããŒãŒããã«ãã³é žãªãã·ããŒ
ãŒãïŒäŸ¡åã³ïŒäŸ¡ã®éœã€ãªã³ãããã¹ããšããŒã«
ãã«ããŒãããã¢ãã³ãããªã³é žãã¢ããã·ã³äž
ãªã³é žãéçé žå¡©ãçºè²æç€ºè¬ç³»äžŠã³ã«å Žåã«ã
ãç¡æ©ãªã³é žå¡©ãçŽ6.5ã9.5ã®PHç¯å²ãæããç·©
è¡å€åã³ããšãã·ã¢ã³åãããªãŠã åã¯ã«ãªãŠã
ãæ¶²äœè©Šæäžã®å°¿çŽ ãæ€åºãããã䜿çšããããš
ãæ¬çºæã®ç®çã§ãããå°¿åã³è¡æ¶²ïŒè¡æŒ¿åã¯è¡
æž ïŒã®ãããªäœæ¶²ãå«ããŠæ¶²äœè©Šæäžã®å°¿çŽ ã®æ€
åºçšã®çµæç©ãæ€åºå ·åã³æ€åºæ¹æ³ãæäŸããã
ãã®çµæç©ã¯å°¿çŽ ã¢ãããªã¢ãŒãŒããã«ãã³é žã
ããŒãŒããã«ãã³é žãªãã·ããŒãŒãïŒäŸ¡éœã€ãª
ã³ã奜ãŸããã¯Mg++ãïŒäŸ¡éœã€ãªã³ã奜ãŸãã
ã¯K+ããã¹ããšããŒã«ãã«ããŒãããã¢ãã³ã
ããªã³é žãã¢ããã·ã³äžãªã³é žïŒATPïŒäžŠã³ã«
éé žåæ°ŽçŽ ãçæãããçé žå¡©åã³çºè²æç€ºè¬
ç³»ã奜ãŸããã¯ãã«ãªãã·ããŒãŒãïŒâã¢ããã
ãšããŸã³åã³ããšããŒã«åã¯çœ®æããšããŒã«ãäŸ
ãã°ïœâããããã·ãã³ãŒã³ã¹ã«ãã³é žåã¯ïŒâ
ããããã·ããšãã«é ¢é žãå«ããçµæç©ã¯ç¡æ©ãª
ã³é žå¡©ãå«ãã®ã奜ãŸããã ãå¯éçãæç€ºè¬ãäŸãã°ïœâãžã¢ãã·ãžã³ã
ããã©ã¡ãã«ãã³ãžãžã³ããã€ã³ææçã䜿çšã
ãããšã«ãã€ãŠéé žåæ°ŽçŽ ã®æ€åºã宿œããããš
ãã§ããããããã«ããŠããçºè²ãå ã®å°¿çŽ æ¿åºŠ
ã«çžé¢ãããããšã«ãã€ãŠæ¯è²æ³ã«ãã€ãŠå®éã
è¡ãã 奜ãŸããã¯çŽ6.5ãçŽ9.5ã®PHã«ç·©è¡ããïŒæäœ
溶液ãšããŠäœ¿çšããããåæ§æããããåã¯æ äœ
ã«æ··å ¥ããŠè©Šéšå ·ãäŸãã°é å€åã¯è©Šè¬ãããªã
ã¯ã¹ãäœãããšã®ã§ãããããããã®åã§çµæç©
ãæäŸããããšãã§ããã æ¬çºæã¯è¥å¹²ã®å©ç¹ãå³ã¡(1)äžã€ã®æäœè©Šè¬ã
䜿çšããŠäŸ¿å©ãªïŒå·¥çšåå¿ãçããã(2)å¯èŠç¯å²
ã®èªã¿åãææšãçããã®ã§ã玫å€ç·èªã¿åãæ
æšã«å¿ èŠãªé«äŸ¡ãªè£ 眮ã¯äžèŠã§ããã(3)ãã®ç³»ã§
èµ·ããåå¿ã¯ã髿ž©åå¿ã§ãªãåã³(4)ãã®æäœã
èªåè£ çœ®ã«å®¹æã«é©åãããããšããå©ç¹ãåã
ãæãããã®ã§ãã€ãŠãéåžžã®äœ¿çšã«é©åãªãã®
ã§ããã æ¬çºæãæŽã«ååã«çè§£ããããã以äžã«æŽã«
詳述ããã 奜ãŸãã宿œæ æ§ã®èª¬æ æ¬çºæã¯å°¿çŽ ã®é µçŽ åæã«ãããå°¿çŽ ã¢ãããª
ã¢ãŒãŒã®äœ¿çšã«åºã¥ããæ¬çºæã«ããçµæç©ã¯ã
æ¶²äœè©Šæäžã®å°¿çŽ ã®ååšã«å¿ããŠãéé žåæ°ŽçŽ ã
çæããé µçŽ ææ®µåã³éé žåæ°ŽçŽ ã«å¿çããŠãè²
ã®å¿çãçããçºè²æç€ºè¬ç³»ãå«ããå°¿çŽ å¿çæ
段ã¯å°¿çŽ ã¢ãããªã¢ãŒãŒïŒE.C.3.5.1.45ïŒããã«ã
ã³é žãããŒãŒïŒE.C.2.7.1.40ïŒåã³ãã«ãã³é žãª
ãã·ããŒãŒïŒE.C.1.2.3.3ïŒãå«ããæŽã«ãã¢ãã
ã·ã³â5â²âäžãªã³é žïŒATPïŒãéçé žå¡©ãéœã€ãª
ã³ããã¹ããšããŒã«ãã«ããŒãïŒPEPïŒåã³ã
ã¢ãã³ãããªã³é žãå¿ èŠã§ããã çµæç©ã«ç¡æ©ãªã³é žå¡©ãæ·»å ããã®ã奜ãŸã
ãã åå¿åŒã¯äžèšã®ãšããã§ããïŒ (1) å°¿çŽ ïŒHCO3 -ïŒATDå°¿çŽ ã¢ãããªã¢ãŒãŒ âââââââââââââââ ïŒäŸ¡åã¯ïŒäŸ¡éœã€ãªã³2NH3ïŒPiïŒ2CO2ïŒADP (2) ADPïŒãã¹ããšããŒã«ãã«ããŒããã«ãã³é žãããŒ
㌠âââââââââââââââ ïŒäŸ¡éœã€ãªã³ãã«ãã³é žå¡©ïŒATP (3) ãã«ãã³é žå¡©ïŒPiïŒO2ãã«ãã³é žãªãã·ã¿ãŒãŒ âââââââââââââââ ãã¢ãã³ãããªã³é žã¢ã»ãã«ãã¹ããšãŒãïŒCO2ïŒH2O2 çæããéé žåæ°ŽçŽ ãæ¬¡ã«çºè²æç€ºè¬ç³»ã䜿çš
ããŠæž¬å®ããããšãã§ããã çºè²æç€ºè¬ç³»ã¯ãäžèšã®åå¿ã«ããããã«ãªã
ã·ããŒãŒãïŒâã¢ããããšããŸã³åã³ããšããŒã«
åã¯çœ®æããšããŒã«ãäŸãã°ïŒâããããã·ããš
ãã«é ¢é žãå«ãã®ã奜ãŸããïŒ (4) çºè²æç€ºè¬æå ïŒH2O2ãã«ãªãã·ã¿ãŒãŒ ââââââââââââ è²çŽ åœ¢æããè²çŽ ã¯éé žåæ°ŽçŽ ãåŸã€ãŠãå°¿çŽ ã®æ¿
åºŠã«æ¯äŸãããåŸã€ãŠãæ¯è²èšåã¯å 床èšãçšã
ãŠå¯èŠç¯å²ãäžè¬ã«400ã700nïœã§åå¿ããæº¶æ¶²
ã®åžå åºŠãæž¬å®ããã ãã§ãå°¿çŽ ã®æ¿åºŠã枬å®ã
ãããšãã§ããã ä»»æã®æå®ã®æéã«çããè²çŽ ã®éãå°¿çŽ ã®æ¿
åºŠã«æ¯äŸããã®ã§ãçµç¹æ³åã¯é床æ³ã䜿çšãã
ããšãã§ããã é µçŽ ã§ããå°¿çŽ ã¢ãããªã¢ãŒãŒã¯ãçš®ã ã®åŸ®ç
ç©ããåŸããããBiol.Chem.ã274ã4107ã4113
ïŒ1972ïŒåç §ã䜿çšããä»ã®é µçŽ ã¯åžè²©ãããŠã
ãã ïŒäŸ¡ã®éœã€ãªã³ãšããŠãMg++åã¯Mn++ã䜿
çšãããããMg++ã奜ãŸãããïŒäŸ¡éœã€ãªã³ã¯
K+ãNH4 +ãRb+åã¯Cs+ã®çŸ€ããéžæãããã
K+ã奜ãŸããã éçé žã€ãªã³æºãšããŠãä»»æã®é©åã«å¯æº¶æ§ã®
éçé žå¡©ãäŸãã°ã¢ã«ã«ãªéå±å¡©åã¯ã¢ã«ã«ãªå
é¡éå±å¡©ã䜿çšããããšãã§ãããéçé žãããª
ãŠã åã¯ã«ãªãŠã ã奜ãŸãããç¡æ©ãªã³é žæºãäŸ
絊ãããããåæ§ã®å¡©ã䜿çšããããšãã§ããã æ¬çºæã«æçšãªéé žåç©æŽ»æ§ãæããç©è³ªã¯ã
çš®ã ã®ææ©åã³ç¡æ©ç©è³ªæºããéžæããããšãã§
ãããçš®ã ã®æ€ç©ãã«ãªãã·ããŒãŒãäŸãã°è¥¿æŽ
ããã³åã¯ãã¬ã€ã·ãšãã«ãªãã·ããŒãŒã䜿çšã
ãããšãã§ãããæŽã«ãããŸã奜ãŸããã¯ãªã
ãããããã³åã³ããã³èªå°äœããã¢ã°ããã³å
ã³ãããã³ã䜿çšããããšãã§ããã äžã€ã®é©åœãªçºè²æç€ºè¬ç³»ã¯ãéé žåç©æŽ»æ§æ
åã奜ãŸããã¯ãã«ãªãã·ããŒãŒãåã³çºè²æç€º
è¬æåã®åå¿ãçµåããããã«ãªãã·ããŒãŒãšå ±
ã«äœ¿çšãããçºè²æç€ºè¬æåã¯ããå¯éçãæç€º
è¬ãäŸãã°ïœâãžã¢ãã·ãžã³ãããã©ã¡ãã«ãã³
ãžãžã³ããã€ã³ææãïŒïŒ2â²âã¢ãžã³âãžïŒãšã
ã«ãã³ãŸãã¢ãŸãªã³âïŒâã¹ã«ãã³é žïŒãã·ãªã³
ã¬ã«ããžã³çãåã³é žåæ§ã«ãããªã³ã°æåãäŸ
ãã°ïŒâã¢ããããšããŸã³è¥ããã¯ãã®èªå°äœå
ã³ããšããŒã«åã¯ããããŒã«ãåã¯è³éŠæã¢ã
ã³ãåã¯ãããã®èªå°äœãåã¯ïŒâã¡ãã«ãã³ãŸ
ãã¢ãŸãªãã³ããã©ãŸã³ïŒMBTHïŒåã³ããšã
ãŒã«åã¯ããããŒã«ãåã¯è³éŠæã¢ãã³åã¯ãã
ãã®èªå°äœãå å«ããã åŸæ¥å ¬ç¥ã®é©åã«çœ®æããã倿°ã®ããšããŒã«
ããæ¬çºæã«äœ¿çšããããšãã§ããããã®ãããª
眮æããšããŒã«ã®äŸã¯ãã¡ã€ãã¿ãïŒMeittaniïŒ
ã®ç±³åœç¹èš±ç¬¬3886045å·æçŽ°æžïŒç±³åœç¹èš±ç¬¬
Re29498å·ãšããŠåçºè¡ãããŠããïŒã«é瀺ãã
ãŠããã®ã§ããããåèæç®ãšããŠæ¬æçްæžã«å«
ããã奜ãŸãã眮æããšããŒã«ã¯ïŒâããããã·
ããšãã«é ¢é žã§ãããæŽã«ãïŒâãïŒâåã³ïŒâ
ããããã·ãã³ãžã«ã¢ã«ã³ãŒã«ãïœâãïœâåã³
ïœâããããã·ãã³ãŒã³ã¹ã«ãã³é žãïŒâã¯ãã
âïŒïŒïŒâã¡ãã«ããšããŒã«åã³ïŒâããããã·
âïŒâã¯ãããã³ãŒã³ã¹ã«ãã³é žã䜿çšããããš
ãã§ãããé©åœãªããããŒã«ã¯ãäŸãã°ïŒâãã
ããŒã«ãïŒâããããŒã«ãïŒâããããã·âïŒâ
ããããšé žåã³ãããã®ã¹ã«ãã³åèªå°äœã§ã
ããé©åœãªè³éŠæã¢ãã³ã¯ãäŸãã°ïŒ®ïŒïŒ®âãžã¡
ãã«âåã³ïŒ®ïŒïŒ®âãžãšãã«âã¢ããªã³ãïŒïŒ®
âãžã¡ãã«âïœâãã«ã€ãžã³ãïŒïŒ®âãžããã
ãã·ãšãã«âïœâåã¯âïœâãã«ã€ãžã³åã³ïŒâ
ïŒïŒ®âãžã¡ãã«ã¢ãã宿¯éŠé žã§ãããåèšå
åç©ã®å¯æº¶æ§å¡©ãäŸãã°ããšããŒã«ãããããŒã«
ã«ã¯ãããªãŠã å¡©åã¯ã«ãªãŠã å¡©ãã¢ãã³é¡ã«ã¯
å¡©é žå¡©ã䜿çšããããšãã§ããã å¥ã®é©åœãªçºè²æç€ºè¬ç³»ã¯ãã¢ã³ã¢ããŠã ã€ãª
ã³åã³Î²âãžã±ãã³ãšã®åå¿ã«ãããžãããã«ã
ãžã³èªå°äœã圢æããåå¿ã«ãããåã¯ïŒâã¢ã
ãâïŒâããã©ãžãâïŒâã¡ã«ã«ããâïŒïŒïŒïŒ
ïŒâããªã¢ãŸãŒã«è¥ããã¯ãã«ã ã¢ã«ããããšçž®
åããŠè²çŽ ãçæãããä»ã®ç©è³ªãšã®åå¿ã«ãã
ã¡ã¿ããŒã«ã®ååšã§çæãããã«ã ã¢ã«ãããã
ç£èŠããããšã«ãã€ãŠã«ã¿ã©ãŒãŒãå©çšããã æåŸã«ãææ©éå±é¯äœãäŸãã°ãã¿ããŠã
ïŒïŒâïŒïŒïŒâããªãžã«ã¢ãŸïŒã¬ãŸã«ã·ããŒã«å
ã¯ãã¿ããŠã ïŒïŒâãã·ã¬ããŒã«ãªã¬ã³ãžã®é ž
åã«ãããé µçŽ ãçšããªãã§è²çŽ ãçæããããš
ãã§ããã äœæ¶²è©Šæäžã®ããªã«ãã³ã®åŠšå®³ãäœæžããããš
ã«ãã€ãŠåæã®ç¹ç°æ§ãå¢å ãããããçš®ã ã®ã¢
ã«ã«ãªéå±ããšãã·ã¢ã³åç©ãäŸãã°ããšãã·ã¢
ã³åã«ãªãŠã ããããªãŠã åã³ã«ã«ã·ãŠã ã䜿çš
ããããšãã§ãããããšãã·ã¢ã³åç©æºãšããŠã
ããšãã·ã¢ã³åã¢ã³ã¢ããŠã åã³ããšãã·ã¢ã³å
ç©çæååç©ã䜿çšããããšãã§ããã å·¥çšå šäœãå¡©åºåã¯é žã§ç·©è¡ããç³»äžã§è¡ãã
é©åœãªç·©è¡å€ã¯ããªã³é žå¡©ãâïŒâããããã·
ãšãã«ããã©ãžã³âNâ²âïŒâãšã¿ã³ã¹ã«ãã³é ž
ïŒHEPESïŒãïŒâïŒïŒ®âã¢ã«ããªãïŒãããã³ã¹
ã«ãã³é žïŒMOPSïŒãããªã¹ïŒããããã·ã¡ã
ã«ïŒâã¢ããã¡ã¿ã³ïŒTRISïŒãâããªã¹ïŒãã
ããã·ã¡ãã«ïŒâã¡ãã«âïŒâã¢ãããšã¿ã³ã¹ã«
ãã³é žïŒTESïŒãâïŒâããããã·ãšãã«ãã
ã©ãžã³ãããã³ã¹ã«ãã³é žïŒEPPSïŒããžãšã¿ã
ãŒã«ã¢ãã³åã³ã°ã«ã¿ã«é žãžã¡ãã«ã§ããã æŽã«ãå®å®åå€ã®ãããªç©è³ªåã³ä»ã®åžžçšã®æ·»
å ç©ãå¿ èŠã«å¿ããŠäœ¿çšããããšãã§ãããçµæ
ç©ã溶å€ãäŸãã°æ°ŽãççåŠç溶液åã¯ææ©æº¶
å€ãäŸãã°ã¡ã¿ããŒã«åã¯ãããã®æ··åç©ãçšã
ãŠè£œé ããæº¶æ¶²ã®åœ¢ã§äœ¿çšããããšãã§ããã æå¹ãªæ¿åºŠç¯å²åã³å¥œé©æ¿åºŠç¯å²ã以äžã«ç€º
ãïŒ
ã衚ã
ã衚ã
é
µçŽ æŽ»æ§ã¯åœéåäœïŒI.U.ïŒã§ç€ºãã1I.U.ã¯ç¹
å®ã®PHåã³æž©åºŠæ¡ä»¶äžã«ïŒåéã«ïŒãã€ã¯ãã¢ã«
ïŒÎŒmolïŒã®ç©è³ªã®å€æãè§Šåªããã®ã«å¿ èŠãªé µçŽ
掻æ§ã®éã§ããã æ¬çºæã«ããçµæç©ãå«ã溶液èªäœããäœæ¶²è©Š
æãäŸãã°å°¿ãè¡æŒ¿åã¯è¡æž ã«æ·»å ããããšã«ã
ã€ãŠå°¿çŽ ãæ€åºãããã䜿çšããããšãã§ããã
詊è¬ããããããã®åãäŸãã°åèšæåã®ïŒçš®ä»¥
äžã溶解ããŠãåã¯äºåæ··åç²æ«ãåã¯åçµä¹Ÿç¥
ããç²æ«ãšããŠå«ãå£åãšããŠæäŸããããšãã§
ãããã®ãããªãããã¯ïŒæäœæº¶æ¶²ãšããŠäœ¿çšã
ãããåæ§æããããšãã§ããããããã¯å Žåã«
ããé©åœãªå°¿çŽ æšæºãå«ãã§ããŠããã åžžçšã®æ äœç©è³ªãå«ãå§çž®åã¯æåœ¢é å€ã®åœ¢ã®
é å€åã¯æ äœãããªãã¯ã¹äžã«çµæç©ãæ··å ¥ããŠ
也åŒè©Šéšå ·ãäœãããšãã§ãããæ¬æçްæžã«ãã
ãŠçšèªãæ äœãããªãã¯ã¹ããšã¯ãç¹å®éã®çµæ
ç©ã嫿ããã®ã«é©åœãªä»»æã®ææ®µã§ããã åŸã€ãŠãæ äœãããªãã¯ã¹ã¯æåãæ··åããã
ä»»æã®ç©è³ªãå«ãã§ããŠãããåŸã€ãŠããããªã
ã¯ã¹ã¯ã倿°ã®å ¬ç¥ã®åœ¢ãäŸãã°æº¶æ¶²åæçšè©Šè¬
ã¹ããªããã«å©çšããã圢ãåãããšãã§ããã
äŸãã°ãç±³åœç¹èš±ç¬¬3846247å·æçŽ°æžã¯ãããšã«
ããå€åæ§ã»ã©ããã¯ã¹ããªããåã³ã¬ã©ã¹ç¹ç¶
ç¹ç©åã¯ãããã®äœ¿çšãæç€ºããŠãããçŽã®ä»£çš
åãšããŠãç±³åœç¹èš±ç¬¬3522928å·æçŽ°æžã¯ãæšæ
ã¹ãã€ãã¯ãåžãã¹ãã³ãžææåã³ç²å質ç©è³ªã®
䜿çšãæç€ºããŠãããçŽã®ä»£ããã«ãåææš¹èã
ãªãŒã¹åã³ã¬ã©ã¹ç¹ç¶ããšã«ãã䜿çšããããš
ã¯ãè±åœç¹èš±ç¬¬1369139å·æçŽ°æžã«ç€ºåãããŠã
ããæŽã«ãè±åœç¹èš±ç¬¬1349623å·æçŽ°æžã¯äžå±€çŽ
ãããªãã¯ã¹çšã«ããŒãšããŠèããã€ã©ã¡ã³ãã®
å ééæ§ã¡ãã·ãŠã䜿çšããããšã瀺åããŠã
ãããã®æçŽ°æžã¯ãæã«ãã®ã¡ãã·ãŠãä»ã®æœåš
çã«éçžæº¶æ§ã®è©Šè¬ã§å«æµžããããšã瀺åããŠã
ãããã©ã³ã¹ç¹èš±ç¬¬2170397å·æçŽ°æžã¯ã50ïŒ ã
ãå€éã®ããªã¢ããç¹ç¶ãå«ãæ äœãããªãã¯ã¹
ã®äœ¿çšã瀺åããŠãããæ äœãããªãã¯ã¹ã«é¢ã
ãå¥ã®ã¢ãããŒãã¯ç±³åœç¹èš±ç¬¬4046513å·æçŽ°æž
ã«é瀺ãããŠãããé©åœãªæ äœãããªãã¯ã¹äžã«
詊è¬ãããªã³ãããæŠå¿µã䜿çšãããŠãããç±³åœ
ç¹èš±ç¬¬4046514å·æçŽ°æžã¯ãåå¿äœç³»ã«è©Šè¬ãä¿
æãããã€ã©ã¡ã³ãã®ç¹ç©åã¯ç·šç©ãé瀺ããŠã
ãã åŸã€ãŠãæ¬çºæã®è©Šéšå ·ã補é ããéã«ããã®
ãããªæ äœãããªãã¯ã¹ããã¹ãŠãä»ã®ãã®ãšå
æ§ã«äœ¿çšããããšãã§ããããããªãã¯ã¹ã¯ãã
ããã®æåã®ä»»æã®ãã®åã¯ãã¹ãŠãäŸãã°æ°Žæº¶
æ¶²ãšæ¥è§Šãããšãç Žå£ããéåäœãã€ã¯ãã«ãã»
ã«ãç©ççã«ææããç³»ãå«ãããšãã§ãããäŸ
ãã°ãïŒçš®ä»¥äžã®é µçŽ åã¯ãã®é µçŽ ã®é žåçæç©
ã«å¿çããææ®µããæº¶æ¶²ãšæ¥è§ŠãããŸã§åå¿ãã
ããšãªããçµæç©ãšåãæ äœãããªãã¯ã¹å ã«
å¥ã ã«ä¿æããããšãã§ããããããªãã¯ã¹ã¯ã
çµæç©æåãæµäœåã¯åæµäœç¶æ ã§åäžã«æ··åã
ãç³»ãå«ã¿ããã®åŸã«ç¡¬åãããŠæåãææããŠ
ããŠãããã ããããªãããçŸåšå¥œãŸããŠããæ¹æ³ã¯ãåžæ°Ž
æ§ãããªãã¯ã¹ãäŸãã°çŽã«çµæç©ã嫿µžã
ããæ¬¡ãã§å«æµžããããããªãã¯ã¹ãæ¯æéšæã«
åºå®ããããšã§ããã嫿µžã¯ãåã«çµæç©äžã«ïŒ
çã®çŽã浞挬ããããšã«ãã€ãŠéæãããã也
ç¥ã¯å«æµžãããçµæç©ã«æªåœ±é¿ãäžããªãä»»æã®
ææ®µãéåžžãé颚çã«ãã€ãŠéæããããšãã§ã
ãã也ç¥ããçŽããã®åŸãåæããæ¯æéšæãäŸ
ãã°ç¡¬è³ªåã¯å硬質ããªã¹ãã¬ã³ãã€ã«ã ã¹ããª
ããã®äžæ¹ã®ç«¯éšã«è²Œä»ãããã¹ããªããäžãžã®
çŽã®è²Œä»ã¯ãäž¡é¢æ¥çããŒããäŸãã°3M瀟ãã
ããã«ã¹ãã€ãã¯ïŒDOUBLE STICKïŒãšã
ãŠåžè²©ããããããŒãã䜿çšããŠéæããããšã
ã§ããã åŸããã詊éšå ·ã詊éšè©Šæäžã«ç¬éçã«æµžæŒ¬ã
ãããåã¯æ äœãããªãã¯ã¹äžã«è©Šéšè©Šæã眮ã
ããšã«ãã€ãŠäœ¿çšããã®ãæå©ã§ãããå°¿çŽ ãå
åšããå Žåã«æ€åºå¯èœãªå€åïŒäŸãã°åè²ïŒãèµ·
ãããæ¹èµ·ããç¹åŸŽçãªåè²åå¿ã¯å°¿çŽ ã®æ¿åºŠã«
å·Šå³ãããã®ã§ãå®éçæ€åºãå¯èœã§ããã äžèšã®å®æœäŸã¯ãæ¬çºæãå±éããéã«å®æœã
ãå®éšã§ãããæ¬çºæã®å¥œãŸãã宿œæ æ§ã説æ
ãããã®ã§ããã宿œäŸã¯æ¬çºæã説æãããã
ã®ãã®ã§ãããæ¬çºæã®ç¯å²ãéå®ãããã®ã§ã¯
ãªããæ¬çºæã®ç¯å²ã¯ç¹èš±è«æ±ã®ç¯å²ã«ãã€ãŠã®
ã¿éå®ããããçµæç©ã®æååã³æ§æèŠçŽ åã³å
å¿ãã©ã¡ãŒã¿ã«ãããæãŸãããšæããããããª
å€åã眮æåã³å€æŽããªãããããšã¯åœæ¥è ã«ã¯
å¯èœã§ããã 宿œäŸ 詊æäžã®å°¿çŽ ãæž¬å®ããçµæç©ãã第衚ã®åŠ
æ¹ã«ããæº¶æ¶²ãšããŠè£œé ãããååŠè¬ååã³é µçŽ
ã¯ãå°¿çŽ ã¢ãããªã¢ãŒãŒãé€ããŠãã¹ãŠåžè²©ãã
ãŠããããã®é µçŽ ã®æŽ»æ§è£œå€ã¯ãã«ãŒã³åã³ã¬ãŒ
ãã³ãã«ã°èããã¡ãœãã ã»ã€ã³ã»ãšã³ãã€ã¢ã
ãžã€ããã³ããŠã€ãã¯åã³ã«ãã©ã³ç·šéïŒã¢ã«ã
ããã¯ã»ãã¬ã¹ãã317ã1970幎ïŒã«èšèŒã
ããŠããããã«å°¿çŽ äžã§å¹é€ããã«ã³ãžãã»ãŠã
ã€ãªã€ã¹ïŒCandida UtilisïŒATCCïŒ8205ã«ãã€
ãŠåŸãããèçœè³ªïŒmgåœãã0.2åäœã®ç¹ç°ç掻
æ§ãæããã 第ïŒè¡š å°¿çŽ æž¬å®çšçµæç© HEPESç·©è¡å€ PH7.5 80ïœïŒ å°¿çŽ ã¢ãããªã¢ãŒãŒ 1I.U.ïŒml ãã«ãã³é žãããŒãŒ 2I.U.ïŒml ãã«ãã³é žãªãã·ããŒãŒ 0.6I.U.ïŒml ãã«ãªãã·ããŒãŒïŒè¥¿æŽããã³ïŒ 1I.U.ïŒml ATP 0.6ïœïŒ ãã¹ããšããŒã«ãã«ããŒã 0.5ïœïŒ KHCO3 0.8ïœïŒ ãã¢ãã³ãããªã³é ž 0.2ïœïŒ K2HPO4 1.0ïœïŒ ïŒâããããã·ããšãã«é ¢é ž 2.5ïœïŒ ïŒâã¢ããããšããŸã³ 0.3ïœïŒ MgSO4 6.0ïœïŒ åèšè©Šè¬æ··åç©2.0mlãå°¿çŽ ãå«ã詊æ0.02ml
ã«æ·»å ãã宀枩ã§15åéæŸçœ®ããããã®æéåŸã
溶液ã®åžå 床ã500nïœã§æž¬å®ããã詊æãå«ãŸ
ãã衚ã«ç€ºãã詊è¬ããã¹ãŠå«ã詊è¬ãã©ã³ã¯ã®
åžå 床ã詊æåžå 床ããå·®ãåŒããçã®åžå 床ã
åŸãã åãæäœã§åŠçããå°¿çŽ æšæºã®æ°å€ãšçµæãæ¯
èŒããããšã«ãã€ãŠè©Šæã®æ°å€ã枬å®ããã ADP溶液ã«å¯Ÿããåå¿ïŒãïŒã«ããå®éšãã
第衚ã«ç€ºãããŒã¿ãåŸããããããã®ããŒã¿ã¯
åå¿ïŒã®ååŠéè«ãä»®å®ããŠãå°¿çŽ æ¿åºŠãšåžå 床
ãšã®äºæãããé¢ä¿ã瀺ãã 第衚 å°¿çŽ æ°Žæº¶æ¶²åæ å°¿çŽ ïŒmgïŒdlïŒ 500nMã§åžå 床 10 0.093 20 0.187 50 0.463 100 0.930 150 1.390 200 1.858 æ¬çºæãããçšåºŠè©³çްã«èšèŒããããæ¬çºæã
äŸã«ãã€ãŠé瀺ãããã®ã§ãããæ¬çºæã®ç¯å²ã
éžè±ããããšãªãã现éšã倿§ã«å€åããããšã
ã§ããã
å®ã®PHåã³æž©åºŠæ¡ä»¶äžã«ïŒåéã«ïŒãã€ã¯ãã¢ã«
ïŒÎŒmolïŒã®ç©è³ªã®å€æãè§Šåªããã®ã«å¿ èŠãªé µçŽ
掻æ§ã®éã§ããã æ¬çºæã«ããçµæç©ãå«ã溶液èªäœããäœæ¶²è©Š
æãäŸãã°å°¿ãè¡æŒ¿åã¯è¡æž ã«æ·»å ããããšã«ã
ã€ãŠå°¿çŽ ãæ€åºãããã䜿çšããããšãã§ããã
詊è¬ããããããã®åãäŸãã°åèšæåã®ïŒçš®ä»¥
äžã溶解ããŠãåã¯äºåæ··åç²æ«ãåã¯åçµä¹Ÿç¥
ããç²æ«ãšããŠå«ãå£åãšããŠæäŸããããšãã§
ãããã®ãããªãããã¯ïŒæäœæº¶æ¶²ãšããŠäœ¿çšã
ãããåæ§æããããšãã§ããããããã¯å Žåã«
ããé©åœãªå°¿çŽ æšæºãå«ãã§ããŠããã åžžçšã®æ äœç©è³ªãå«ãå§çž®åã¯æåœ¢é å€ã®åœ¢ã®
é å€åã¯æ äœãããªãã¯ã¹äžã«çµæç©ãæ··å ¥ããŠ
也åŒè©Šéšå ·ãäœãããšãã§ãããæ¬æçްæžã«ãã
ãŠçšèªãæ äœãããªãã¯ã¹ããšã¯ãç¹å®éã®çµæ
ç©ã嫿ããã®ã«é©åœãªä»»æã®ææ®µã§ããã åŸã€ãŠãæ äœãããªãã¯ã¹ã¯æåãæ··åããã
ä»»æã®ç©è³ªãå«ãã§ããŠãããåŸã€ãŠããããªã
ã¯ã¹ã¯ã倿°ã®å ¬ç¥ã®åœ¢ãäŸãã°æº¶æ¶²åæçšè©Šè¬
ã¹ããªããã«å©çšããã圢ãåãããšãã§ããã
äŸãã°ãç±³åœç¹èš±ç¬¬3846247å·æçŽ°æžã¯ãããšã«
ããå€åæ§ã»ã©ããã¯ã¹ããªããåã³ã¬ã©ã¹ç¹ç¶
ç¹ç©åã¯ãããã®äœ¿çšãæç€ºããŠãããçŽã®ä»£çš
åãšããŠãç±³åœç¹èš±ç¬¬3522928å·æçŽ°æžã¯ãæšæ
ã¹ãã€ãã¯ãåžãã¹ãã³ãžææåã³ç²å質ç©è³ªã®
䜿çšãæç€ºããŠãããçŽã®ä»£ããã«ãåææš¹èã
ãªãŒã¹åã³ã¬ã©ã¹ç¹ç¶ããšã«ãã䜿çšããããš
ã¯ãè±åœç¹èš±ç¬¬1369139å·æçŽ°æžã«ç€ºåãããŠã
ããæŽã«ãè±åœç¹èš±ç¬¬1349623å·æçŽ°æžã¯äžå±€çŽ
ãããªãã¯ã¹çšã«ããŒãšããŠèããã€ã©ã¡ã³ãã®
å ééæ§ã¡ãã·ãŠã䜿çšããããšã瀺åããŠã
ãããã®æçŽ°æžã¯ãæã«ãã®ã¡ãã·ãŠãä»ã®æœåš
çã«éçžæº¶æ§ã®è©Šè¬ã§å«æµžããããšã瀺åããŠã
ãããã©ã³ã¹ç¹èš±ç¬¬2170397å·æçŽ°æžã¯ã50ïŒ ã
ãå€éã®ããªã¢ããç¹ç¶ãå«ãæ äœãããªãã¯ã¹
ã®äœ¿çšã瀺åããŠãããæ äœãããªãã¯ã¹ã«é¢ã
ãå¥ã®ã¢ãããŒãã¯ç±³åœç¹èš±ç¬¬4046513å·æçŽ°æž
ã«é瀺ãããŠãããé©åœãªæ äœãããªãã¯ã¹äžã«
詊è¬ãããªã³ãããæŠå¿µã䜿çšãããŠãããç±³åœ
ç¹èš±ç¬¬4046514å·æçŽ°æžã¯ãåå¿äœç³»ã«è©Šè¬ãä¿
æãããã€ã©ã¡ã³ãã®ç¹ç©åã¯ç·šç©ãé瀺ããŠã
ãã åŸã€ãŠãæ¬çºæã®è©Šéšå ·ã補é ããéã«ããã®
ãããªæ äœãããªãã¯ã¹ããã¹ãŠãä»ã®ãã®ãšå
æ§ã«äœ¿çšããããšãã§ããããããªãã¯ã¹ã¯ãã
ããã®æåã®ä»»æã®ãã®åã¯ãã¹ãŠãäŸãã°æ°Žæº¶
æ¶²ãšæ¥è§Šãããšãç Žå£ããéåäœãã€ã¯ãã«ãã»
ã«ãç©ççã«ææããç³»ãå«ãããšãã§ãããäŸ
ãã°ãïŒçš®ä»¥äžã®é µçŽ åã¯ãã®é µçŽ ã®é žåçæç©
ã«å¿çããææ®µããæº¶æ¶²ãšæ¥è§ŠãããŸã§åå¿ãã
ããšãªããçµæç©ãšåãæ äœãããªãã¯ã¹å ã«
å¥ã ã«ä¿æããããšãã§ããããããªãã¯ã¹ã¯ã
çµæç©æåãæµäœåã¯åæµäœç¶æ ã§åäžã«æ··åã
ãç³»ãå«ã¿ããã®åŸã«ç¡¬åãããŠæåãææããŠ
ããŠãããã ããããªãããçŸåšå¥œãŸããŠããæ¹æ³ã¯ãåžæ°Ž
æ§ãããªãã¯ã¹ãäŸãã°çŽã«çµæç©ã嫿µžã
ããæ¬¡ãã§å«æµžããããããªãã¯ã¹ãæ¯æéšæã«
åºå®ããããšã§ããã嫿µžã¯ãåã«çµæç©äžã«ïŒ
çã®çŽã浞挬ããããšã«ãã€ãŠéæãããã也
ç¥ã¯å«æµžãããçµæç©ã«æªåœ±é¿ãäžããªãä»»æã®
ææ®µãéåžžãé颚çã«ãã€ãŠéæããããšãã§ã
ãã也ç¥ããçŽããã®åŸãåæããæ¯æéšæãäŸ
ãã°ç¡¬è³ªåã¯å硬質ããªã¹ãã¬ã³ãã€ã«ã ã¹ããª
ããã®äžæ¹ã®ç«¯éšã«è²Œä»ãããã¹ããªããäžãžã®
çŽã®è²Œä»ã¯ãäž¡é¢æ¥çããŒããäŸãã°3M瀟ãã
ããã«ã¹ãã€ãã¯ïŒDOUBLE STICKïŒãšã
ãŠåžè²©ããããããŒãã䜿çšããŠéæããããšã
ã§ããã åŸããã詊éšå ·ã詊éšè©Šæäžã«ç¬éçã«æµžæŒ¬ã
ãããåã¯æ äœãããªãã¯ã¹äžã«è©Šéšè©Šæã眮ã
ããšã«ãã€ãŠäœ¿çšããã®ãæå©ã§ãããå°¿çŽ ãå
åšããå Žåã«æ€åºå¯èœãªå€åïŒäŸãã°åè²ïŒãèµ·
ãããæ¹èµ·ããç¹åŸŽçãªåè²åå¿ã¯å°¿çŽ ã®æ¿åºŠã«
å·Šå³ãããã®ã§ãå®éçæ€åºãå¯èœã§ããã äžèšã®å®æœäŸã¯ãæ¬çºæãå±éããéã«å®æœã
ãå®éšã§ãããæ¬çºæã®å¥œãŸãã宿œæ æ§ã説æ
ãããã®ã§ããã宿œäŸã¯æ¬çºæã説æãããã
ã®ãã®ã§ãããæ¬çºæã®ç¯å²ãéå®ãããã®ã§ã¯
ãªããæ¬çºæã®ç¯å²ã¯ç¹èš±è«æ±ã®ç¯å²ã«ãã€ãŠã®
ã¿éå®ããããçµæç©ã®æååã³æ§æèŠçŽ åã³å
å¿ãã©ã¡ãŒã¿ã«ãããæãŸãããšæããããããª
å€åã眮æåã³å€æŽããªãããããšã¯åœæ¥è ã«ã¯
å¯èœã§ããã 宿œäŸ 詊æäžã®å°¿çŽ ãæž¬å®ããçµæç©ãã第衚ã®åŠ
æ¹ã«ããæº¶æ¶²ãšããŠè£œé ãããååŠè¬ååã³é µçŽ
ã¯ãå°¿çŽ ã¢ãããªã¢ãŒãŒãé€ããŠãã¹ãŠåžè²©ãã
ãŠããããã®é µçŽ ã®æŽ»æ§è£œå€ã¯ãã«ãŒã³åã³ã¬ãŒ
ãã³ãã«ã°èããã¡ãœãã ã»ã€ã³ã»ãšã³ãã€ã¢ã
ãžã€ããã³ããŠã€ãã¯åã³ã«ãã©ã³ç·šéïŒã¢ã«ã
ããã¯ã»ãã¬ã¹ãã317ã1970幎ïŒã«èšèŒã
ããŠããããã«å°¿çŽ äžã§å¹é€ããã«ã³ãžãã»ãŠã
ã€ãªã€ã¹ïŒCandida UtilisïŒATCCïŒ8205ã«ãã€
ãŠåŸãããèçœè³ªïŒmgåœãã0.2åäœã®ç¹ç°ç掻
æ§ãæããã 第ïŒè¡š å°¿çŽ æž¬å®çšçµæç© HEPESç·©è¡å€ PH7.5 80ïœïŒ å°¿çŽ ã¢ãããªã¢ãŒãŒ 1I.U.ïŒml ãã«ãã³é žãããŒãŒ 2I.U.ïŒml ãã«ãã³é žãªãã·ããŒãŒ 0.6I.U.ïŒml ãã«ãªãã·ããŒãŒïŒè¥¿æŽããã³ïŒ 1I.U.ïŒml ATP 0.6ïœïŒ ãã¹ããšããŒã«ãã«ããŒã 0.5ïœïŒ KHCO3 0.8ïœïŒ ãã¢ãã³ãããªã³é ž 0.2ïœïŒ K2HPO4 1.0ïœïŒ ïŒâããããã·ããšãã«é ¢é ž 2.5ïœïŒ ïŒâã¢ããããšããŸã³ 0.3ïœïŒ MgSO4 6.0ïœïŒ åèšè©Šè¬æ··åç©2.0mlãå°¿çŽ ãå«ã詊æ0.02ml
ã«æ·»å ãã宀枩ã§15åéæŸçœ®ããããã®æéåŸã
溶液ã®åžå 床ã500nïœã§æž¬å®ããã詊æãå«ãŸ
ãã衚ã«ç€ºãã詊è¬ããã¹ãŠå«ã詊è¬ãã©ã³ã¯ã®
åžå 床ã詊æåžå 床ããå·®ãåŒããçã®åžå 床ã
åŸãã åãæäœã§åŠçããå°¿çŽ æšæºã®æ°å€ãšçµæãæ¯
èŒããããšã«ãã€ãŠè©Šæã®æ°å€ã枬å®ããã ADP溶液ã«å¯Ÿããåå¿ïŒãïŒã«ããå®éšãã
第衚ã«ç€ºãããŒã¿ãåŸããããããã®ããŒã¿ã¯
åå¿ïŒã®ååŠéè«ãä»®å®ããŠãå°¿çŽ æ¿åºŠãšåžå 床
ãšã®äºæãããé¢ä¿ã瀺ãã 第衚 å°¿çŽ æ°Žæº¶æ¶²åæ å°¿çŽ ïŒmgïŒdlïŒ 500nMã§åžå 床 10 0.093 20 0.187 50 0.463 100 0.930 150 1.390 200 1.858 æ¬çºæãããçšåºŠè©³çްã«èšèŒããããæ¬çºæã
äŸã«ãã€ãŠé瀺ãããã®ã§ãããæ¬çºæã®ç¯å²ã
éžè±ããããšãªãã现éšã倿§ã«å€åããããšã
ã§ããã
Claims (1)
- ãç¹èš±è«æ±ã®ç¯å²ã ïŒ æ¶²äœè©Šæäžã®å°¿çŽ ã®é µçŽ æž¬å®çšçµæç©ã«ãã
ãŠãå°¿çŽ ã¢ãããªã¢ãŒãŒããã«ãã³é žãããŒãŒã
ãã«ãã³é žãªãã·ããŒãŒãïŒäŸ¡éœã€ãªã³ãïŒäŸ¡éœ
ã€ãªã³ããã¹ããšããŒã«ãã«ããŒãããã¢ãã³ã
ããªã³é žãã¢ããã·ã³äžãªã³é žãéçé žå¡©åã³çº
è²æç€ºè¬ç³»ãå«ãå°¿çŽ ã®é µçŽ æž¬å®çšçµæç©ã ïŒ æŽã«ãç¡æ©ãªã³é žå¡©ãå«ãç¹èš±è«æ±ã®ç¯å²ç¬¬
ïŒé èšèŒã®çµæç©ã ïŒ çºè²æç€ºè¬ç³»ãéé žåç©æŽ»æ§è©Šè¬åã³çºè²æ
ç€ºè¬æåã§ããç¹èš±è«æ±ã®ç¯å²ç¬¬ïŒé èšèŒã®çµæ
ç©ã ïŒ éé žåç©æŽ»æ§è©Šè¬ããã«ãªãã·ããŒãŒã§ãã
ç¹èš±è«æ±ã®ç¯å²ç¬¬ïŒé èšèŒã®çµæç©ã ïŒ çºè²æç€ºè¬æåãå¯éçæç€ºè¬ã§ããç¹èš±è«
æ±ã®ç¯å²ç¬¬ïŒé èšèŒã®çµæç©ã ïŒ çºè²æç€ºè¬æåãé žåæ§ã«ãããªã³ã°æåã§
ããç¹èš±è«æ±ã®ç¯å²ç¬¬ïŒé èšèŒã®çµæç©ã ïŒ é žåæ§ã«ãããªã³ã°æåãïŒâã¢ããããšã
ãŸã³åã³ããšããŒã«ãããããŒã«åã¯è³éŠæã¢ã
ã³ãå«ãç¹èš±è«æ±ã®ç¯å²ç¬¬ïŒé èšèŒã®çµæç©ã ïŒ çŽ6.5ã9.5ã®ç¯å²ã®PHãæããç·©è¡å€ãæŽã«
å«ãç¹èš±è«æ±ã®ç¯å²ç¬¬ïŒé èšèŒã®çµæç©ã ïŒ ããšãã·ã¢ã³åãããªãŠã åã¯ã«ãªãŠã ãæŽ
ã«å«ãç¹èš±è«æ±ã®ç¯å²ç¬¬ïŒé èšèŒã®çµæç©ã ïŒïŒ ïŒäŸ¡éœã€ãªã³ããã°ãã·ãŠã éœã€ãªã³ã§ã
ããïŒäŸ¡éœã€ãªã³ãã«ãªãŠã éœã€ãªã³ã§ãããçº
è²æç€ºè¬ç³»ããã«ãªãã·ããŒãŒãïŒâã¢ããããš
ããŸã³åã³ïŒâããããã·ããšãã«é ¢é žãå«ãã
ã®ã§ããç¹èš±è«æ±ã®ç¯å²ç¬¬ïŒé èšèŒã®çµæç©ã ïŒïŒ çŽ6.5ã9.5ã®ç¯å²ã®PHãæããç·©è¡å€ãå«
ãç¹èš±è«æ±ã®ç¯å²ç¬¬ïŒïŒé èšèŒã®çµæç©ã ïŒïŒ ããšãã·ã¢ã³åãããªãŠã åã¯ã«ãªãŠã ã
å«ãç¹èš±è«æ±ã®ç¯å²ç¬¬ïŒïŒé èšèŒã®çµæç©ã
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT48827A/83 | 1983-08-08 | ||
| IT48827/83A IT1205338B (it) | 1983-08-09 | 1983-08-09 | Composizione e metodo per la determinazione enzimatica di urea in liquidi organici |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS6054699A JPS6054699A (ja) | 1985-03-29 |
| JPH0332360B2 true JPH0332360B2 (ja) | 1991-05-10 |
Family
ID=11268706
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP59155638A Granted JPS6054699A (ja) | 1983-08-09 | 1984-07-27 | å°¿çŽ ã®é µçŽ æž¬å®çšçµæç© |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US4608335A (ja) |
| EP (1) | EP0133681B1 (ja) |
| JP (1) | JPS6054699A (ja) |
| AT (1) | ATE37199T1 (ja) |
| AU (1) | AU572535B2 (ja) |
| CA (1) | CA1220122A (ja) |
| DE (1) | DE3474041D1 (ja) |
| IT (1) | IT1205338B (ja) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CH664975A5 (fr) * | 1985-03-15 | 1988-04-15 | Battelle Memorial Institute | Procede analytique pour la determination d'un coenzyme reduit. |
| US5221615A (en) * | 1985-11-14 | 1993-06-22 | Ivan E. Modrovich | Liquid stable triglyceride reagent system |
| US5139934A (en) * | 1990-05-25 | 1992-08-18 | Becton, Dickinson And Company | Substrate composition and method for solid phase urease immunoassay |
| JP2595141B2 (ja) * | 1991-05-16 | 1997-03-26 | è²¡å£æ³äºº ãã æ°Žæºå°ç°å¢æŽåã»ã³ã¿ãŒ | ãªã³é žã€ãªã³æ¿åºŠæž¬å®è£ 眮 |
| US5334507A (en) * | 1991-09-20 | 1994-08-02 | Toyo Boseki Kabushiki Kaisha | Composition for measurement of potassium ion concentration and composition for elimination of ammonium ions |
| DE4436948A1 (de) * | 1994-10-15 | 1996-04-18 | Merck Patent Gmbh | Mittel und Verfahren zur Bestimmung von Ammoniumionen |
| GB9626932D0 (en) * | 1996-12-24 | 1997-02-12 | Lumitech Limited | Assay methods and kits therefor |
| US7790690B2 (en) | 2000-10-11 | 2010-09-07 | U.S. Department Of Veterans Affairs | Glucose sensitive regulator of insulin transcription |
| US8187831B2 (en) * | 2003-09-19 | 2012-05-29 | General Atomics | Determination of ions using ion-sensitive enzymes |
| US7022494B2 (en) * | 2003-09-19 | 2006-04-04 | General Atomics | Detection of potassium ions using ion-sensitive enzymes |
| US20050191704A1 (en) * | 2004-03-01 | 2005-09-01 | Kimberly-Clark Worldwide, Inc. | Assay devices utilizing chemichromic dyes |
| GB0406427D0 (en) * | 2004-03-22 | 2004-04-21 | Health Prot Agency | Biological indicator |
| US8617366B2 (en) * | 2005-12-12 | 2013-12-31 | Nova Biomedical Corporation | Disposable urea sensor and system for determining creatinine and urea nitrogen-to-creatinine ratio in a single device |
| GB2538724A (en) * | 2015-05-26 | 2016-11-30 | Imp Innovations Ltd | Methods |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3655516A (en) * | 1969-10-10 | 1972-04-11 | Univ Michigan | Urea assay process and composition |
| US4059407A (en) * | 1976-04-14 | 1977-11-22 | Becton, Dickinson And Company | Disposable chemical indicators |
| DD137384B1 (de) * | 1977-11-04 | 1981-07-29 | Kallies Karl Heinz | Indikator-kapillar-roehrchen zur harnstoff-bestimmung |
| US4194063A (en) * | 1978-02-24 | 1980-03-18 | Eastman Kodak Company | Method, composition and elements for the detecting of nitrogen-containing compounds |
| US4246342A (en) * | 1978-03-25 | 1981-01-20 | Toyo Jozo Kabushiki Kaisha | Process for the manufacture of pyruvate oxidase, and analytical method and kit for the use of the same |
| DE3271643D1 (en) * | 1981-07-08 | 1986-07-17 | Ici Plc | Method for the purification of urease and glutamate dehydrogenase |
| JPS6041500A (ja) * | 1983-08-12 | 1985-03-05 | Yamasa Shoyu Co Ltd | ã¢ã³ã¢ãã¢ã®å®éæ³ |
-
1983
- 1983-08-09 IT IT48827/83A patent/IT1205338B/it active
-
1984
- 1984-06-08 US US06/618,831 patent/US4608335A/en not_active Expired - Lifetime
- 1984-06-12 CA CA000456374A patent/CA1220122A/en not_active Expired
- 1984-07-27 JP JP59155638A patent/JPS6054699A/ja active Granted
- 1984-07-30 AT AT84108995T patent/ATE37199T1/de not_active IP Right Cessation
- 1984-07-30 DE DE8484108995T patent/DE3474041D1/de not_active Expired
- 1984-07-30 EP EP84108995A patent/EP0133681B1/en not_active Expired
- 1984-08-01 AU AU31381/84A patent/AU572535B2/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| EP0133681B1 (en) | 1988-09-14 |
| JPS6054699A (ja) | 1985-03-29 |
| CA1220122A (en) | 1987-04-07 |
| US4608335A (en) | 1986-08-26 |
| IT1205338B (it) | 1989-03-15 |
| EP0133681A2 (en) | 1985-03-06 |
| IT8348827A0 (it) | 1983-08-09 |
| EP0133681A3 (en) | 1986-03-12 |
| ATE37199T1 (de) | 1988-09-15 |
| DE3474041D1 (en) | 1988-10-20 |
| AU3138184A (en) | 1985-02-14 |
| AU572535B2 (en) | 1988-05-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Fossati et al. | Use of 3, 5-dichloro-2-hydroxybenzenesulfonic acid/4-aminophenazone chromogenic system in direct enzymic assay of uric acid in serum and urine. | |
| US4321397A (en) | 4-Aminoantipyrine dye for the analytic determination of hydrogen peroxide | |
| EP0471391B1 (en) | Determination of ions in fluids | |
| US4247631A (en) | Reagent and method for the analytic determination of hydrogen peroxide | |
| US5384247A (en) | Determination of sodium ions in fluids | |
| US4251629A (en) | Determination of hydrogen peroxide | |
| US4613569A (en) | Stabilized composition of tetrazolium salts | |
| US4425427A (en) | Simultaneous, kinetic, spectrophotometric analysis of blood serum for multiple components | |
| EP0200540B1 (en) | Analytical element and method for determination of creatine kinase isoenzyme | |
| US4215197A (en) | Test means and method for creatinine determination | |
| JPH02174695A (ja) | é µçŽ é žåã«ããã¢ãã©ã€ãã®æ¯è²å®éæ¹æ³ããã³è©Šå€ãããã³ãã®ããã®éå çºè²æ§é»ååå®¹äœ | |
| JPH0332360B2 (ja) | ||
| JPH0470000B2 (ja) | ||
| US3732147A (en) | Colorimetric determination of dehydrogenases | |
| US4547461A (en) | Composition, analytical element and method for the quantification of creatine kinase | |
| FI77896C (fi) | Komposition foer bestaemning av urinsyra eller kolesterol i ett vaetskeprov. | |
| US4806415A (en) | Method and system for determining the presence of adenosine triphosphate or flavin mononucleotide | |
| US4176008A (en) | Method, composition and element for the detection of nitrogen-containing compounds | |
| WO1989005356A1 (en) | Assay of salicylates or reduced pyridine nucleotides | |
| CA1206077A (en) | Sensitive enzymatic creatinine assay | |
| JPS60210998A (ja) | ç¡æ©ãªã³é žå¡©ã®é µçŽ åŠç枬å®çšè©Šéšçµæç©ã詊éšå ·åã³è©Šé𿹿³ | |
| EP0138530A2 (en) | Method for the estimation of salicylates or reduced Pyridine nucleotides | |
| JPH1099098A (ja) | ãã¬ãããŒã¹åæçšè©Šè¬ | |
| US5487978A (en) | Method, composition and device for the determination of cholesterol using cholesterol oxidase obtained from bacterial strain NRRL B-18713 | |
| JPH03133396A (ja) | ã¢ã³ã¢ãã¢åæçšè©Šè¬çµæç©åã³ãããå«ãäžäœåå€å±€åæèŠçŽ |